D07AA Corticosteroids, weak (group I)

RX_D07AA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — D07AA 1 out of 7 registries used, show all original rules.	8209
4. Check minimum number of events Min. number of events 3	8209
5. Include endpoints None	8209
6. Filter based on genotype QC (FinnGen only)	7390

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	RX_D07AA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	D07AA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to D07AA Corticosteroids, weak (group I) based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7390	4738	2652
Unadjusted period prevalence (%)	1.51	1.68	1.22
Median age at first event (years)	33.02	27.96	42.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7672: Matched controls
76587

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D07XB05

ATC

dexamethasone; topical

7.4

322.3

481

683

H02AB06

ATC

prednisolone; systemic

2.5

318.7

4121

24533

D07AC14

ATC

methylprednisolone aceponate; topical

5.2

316.7

696

1445

D07AB01

ATC

clobetasone; topical

6.4

315.4

543

897

E000004, ,

ATC

9.0

307.7

506

598

E000002, ,

ATC

10.6

307.7

3229

4900

R06AX27

ATC

desloratadine; oral

2.8

307.7

3492

17730

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

30.7

307.7

1119

423

R06AE09

ATC

levocetirizine; oral

3.5

307.7

2015

7146

D07AC13

ATC

mometasone; topical

5.0

307.7

3939

13451

D07BC01

ATC

betamethasone and antiseptics; topical

3.7

307.7

1393

4331

E000006, ,

ATC

8.3

307.7

1506

2183

E000001, ,

ATC

10.1

307.7

4545

9639

D07AC01

ATC

betamethasone; topical

4.5

307.7

4483

18098

E000003, ,

ATC

11.3

307.7

1319

1380

D02AX

ATC

Other emollients and protectives

7.8

307.7

861

1229

D11AH01

ATC

tacrolimus; topical

32.6

307.7

713

240

S01GX01

ATC

cromoglicic acid; ophthalmic

3.6

307.7

2811

10675

D07AB08

ATC

desonide; topical

8.5

307.7

2652

4502

R06AX13

ATC

loratadine; oral

3.4

307.7

2048

7411

D11AH02

ATC

pimecrolimus; topical

38.7

307.7

345

L20

ICD-10 Finland

Atopic dermatitis

8.6

307.7

1143

1526

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.1

307.7

1470

4212

D07BA04

ATC

hydrocortisone and antiseptics; topical

9.0

307.7

2887

4820

E0000UV, ,

ATC

15.6

307.7

6732

24082

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.9

307.7

2137

8875

D07CC01

ATC

betamethasone and antibiotics; topical

3.5

307.7

1497

4955

N05BB01

ATC

hydroxyzine; systemic

8.9

307.7

1640

2260

R06AX22

ATC

ebastine; oral

3.0

307.7

1998

8019

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

4.9

307.7

2246

5923

S87

ICPC

Dermatitis/atopic eczema

7.0

307.7

658

1019

D11AX15

ATC

[U] pimecrolimus

55.6

307.7

227

E000007, ,

ATC

8.3

307.7

1397

2007

D02AE01

ATC

carbamide; topical

6.1

307.7

1184

2224

D11AX14

ATC

[U] tacrolimus

62.8

307.7

445

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

5.4

307.7

855

1740

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

24.4

307.7

472

205

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

17.6

307.7

479

288

D07AA02

ATC

hydrocortisone; topical

+∞

307.7

7672

6517

R06AE07

ATC

cetirizine; oral

4.4

307.7

5335

26063

L20.0

ICD-10 Finland

Besnier prurigo

11.7

307.7

3154

4299

D07AB02

ATC

hydrocortisone butyrate; topical

6.0

307.7

4514

14729

L27.2

ICD-10 Finland

Dermatitis due to ingested food

8.7

296.3

385

464

C01CA24

ATC

epinephrine; parenteral

3.8

294.8

994

2869

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.3

292.7

1249

4203

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

10.8

282.2

309

296

D07XC01

ATC

betamethasone; topical

3.2

276.2

1255

4378

D07CA01

ATC

hydrocortisone and antibiotics; topical

3.0

275.6

1466

5600

D07AD01

ATC

clobetasol; topical

2.7

238.5

1599

6856

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.2

230.1

1040

3594

XQ800

NOMESCO Finland

Prick test

3.1

218.0

1017

3575

R03AC02

ATC

salbutamol; inhalant

2.1

215.9

4816

33718

D09AB01

ATC

zinc bandage without supplements; topical

7.3

215.0

320

451

J01DA01

ATC

[U] cefalexin

2.1

209.2

4967

35412

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

206.3

1833

8903

R03BA02

ATC

budesonide; inhalant

2.4

200.3

1769

8556

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.3

199.3

1980

10072

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.2

194.8

2111

11116

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

7.2

194.2

295

425

D06AX01

ATC

fusidic acid; topical

2.9

193.7

1069

4112

R03DC03

ATC

montelukast; oral

2.4

193.4

1696

8163

XQ802

NOMESCO Finland

Epicutan test

4.0

192.4

583

1547

S01GX02

ATC

levocabastine; ophthalmic

3.4

184.9

729

2306

R03BA05

ATC

fluticasone; inhalant

2.3

182.7

1840

9367

R06AX18

ATC

acrivastine; oral

5.3

171.6

356

697

S01GX08

ATC

ketotifen; ophthalmic

3.4

168.8

645

1997

D11AH05

ATC

dupilumab; topical

23.4

166.4

120

S01BA01

ATC

dexamethasone; ophthalmic

4.7

166.3

400

888

J45

ICD-10 Finland

Asthma

2.6

165.1

1101

4642

R03AC03

ATC

terbutaline; inhalant

2.4

163.2

1319

6080

H02AB07

ATC

prednisone; oral

2.5

162.9

1145

4949

395

Kela drug reimbursment

Dupilumab

24.0

162.4

116

L26

ICD-10 Finland

Exfoliative dermatitis

35.2

160.4

101

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

160.2

3044

19418

134

Kela drug reimbursment

General erythroderma

18.5

149.5

119

S01AD03

ATC

aciclovir; ophthalmic

4.2

144.4

396

973

R06AX26

ATC

fexofenadine; oral

2.8

139.9

767

2917

J01DA09

ATC

[U] cefadroxil

1.9

130.0

2180

13150

L04AA01

ATC

[U] ciclosporin

7.1

129.4

196

281

R96

ICPC

Asthma

2.5

127.4

924

4025

L20.8

ICD-10 Finland

Other atopic dermatitis

5.9

122.3

221

380

J01DB01

ATC

cefalexin; oral

2.1

121.6

6414

54350

L30.3

ICD-10 Finland

Infective dermatitis

3.6

121.6

413

1180

H02AB04

ATC

methylprednisolone; systemic

2.2

121.3

1137

5529

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

119.0

742

3004

R01AD09

ATC

mometasone; nasal

1.7

118.9

3754

27190

R03BA01

ATC

beclometasone; inhalant

2.2

115.5

1124

5542

TQW80

NOMESCO Finland

Local dermatologic skincare

4.3

113.8

303

727

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.7

112.8

373

1046

A46

ICD-10 Finland

Erysipelas

2.2

112.7

1042

5029

R01AD08

ATC

fluticasone; nasal

1.8

111.0

2339

15014

R01AC01

ATC

cromoglicic acid; nasal

3.2

107.8

459

1510

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

107.8

1127

5705

J01FF01

ATC

clindamycin; systemic

1.8

103.2

2007

12527

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.8

102.3

2113

13423

N05BA01

ATC

diazepam; systemic, rectal

2.2

100.3

999

4953

R03AC12

ATC

salmeterol; inhalant

3.2

94.4

381

1213

N05CD07

ATC

temazepam; oral

2.3

92.6

735

3312

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

89.9

860

4186

R06AX12

ATC

terfenadine; oral

2.9

88.9

431

1525

N05CF01

ATC

zopiclone; oral

1.7

87.2

2103

13847

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

85.5

1722

10769

Z51.6

ICD-10 Finland

Desensitization to allergens

4.4

85.1

217

503

B00.10

ICD-10 Finland

Herpes simplex facialis

5.9

85.0

153

262

S01GX09

ATC

olopatadine; ophthalmic

3.3

83.9

327

1018

R01AD01

ATC

beclometasone; nasal

1.9

83.0

1165

6509

49300

ICD-8 Finland

Asthma, bronchiale

4.1

81.2

225

556

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

80.9

1944

12742

A06AD11

ATC

lactulose; oral

2.0

80.2

961

5081

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

80.2

511

2080

J45.8

ICD-10 Finland

Mixed asthma

3.3

77.4

302

941

D06BB03

ATC

aciclovir; topical

2.8

77.2

401

1471

E000005, ,

ATC

31.4

76.6

D07CB01

ATC

triamcinolone and antibiotics; topical

4.3

76.5

201

477

D01AC02

ATC

miconazole; topical

2.4

75.3

544

2345

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

75.2

2197

15097

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.8

74.0

380

1385

N02AX02

ATC

tramadol; systemic, rectal

1.6

72.5

2754

20106

R06AX11

ATC

astemizole; oral

3.0

72.5

330

1126

D07XA01

ATC

hydrocortisone; topical

12.1

71.8

R01AD05

ATC

budesonide; nasal

2.3

71.7

594

2717

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

70.9

2975

22181

L04AD01

ATC

ciclosporin; systemic

3.9

70.8

210

545

N06AX11

ATC

mirtazapine; oral

1.6

70.8

2455

17528

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

68.4

1687

11061

N05AH04

ATC

quetiapine; oral

1.7

68.1

1499

9533

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.2

68.0

142

279

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.9

67.9

337

1206

J05AB01

ATC

aciclovir; systemic

1.7

67.3

1610

10466

R03BB04

ATC

tiotropium bromide; inhalant

2.2

67.3

612

2907

S29

ICPC

Skin symptom/complaint other

1.7

66.7

1547

9972

S01BA04

ATC

prednisolone; ophthalmic

4.0

66.6

191

484

J30.3

ICD-10 Finland

Other allergic rhinitis

2.6

66.5

400

1581

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

8.2

65.6

107

J46

ICD-10 Finland

Status asthmaticus

3.2

65.5

273

885

N05BA04

ATC

oxazepam; oral

1.6

65.4

1900

12956

N06AA12

ATC

doxepin; systemic

2.7

65.4

358

1349

Z3231

NOMESCO Finland

Registered nurse

1.6

64.4

1930

13252

R03AC13

ATC

formoterol; inhalant

2.6

64.2

379

1484

J02AC01

ATC

fluconazole; systemic

1.5

62.9

2890

21815

N03AX12

ATC

[U] gabapentin; oral

1.8

62.4

1058

6231

N06AB04

ATC

citalopram; systemic

1.7

61.6

1419

9106

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

61.3

1912

13231

S01GX06

ATC

emedastine; ophthalmic

4.7

61.1

141

302

R01AD12

ATC

fluticasone furoate; nasal

1.5

61.0

2591

19203

C03CA01

ATC

furosemide; systemic

1.7

61.0

1519

9947

R03BC01

ATC

cromoglicic acid; inhalant

3.8

60.4

184

487

D07XB02

ATC

triamcinolone; topical

4.7

59.4

138

297

S21

ICPC

Skin texture symptom/complaint

1.8

59.2

1127

6859

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

58.7

873

4934

J05AB11

ATC

valaciclovir; oral

1.8

58.2

1058

6353

D05AX52

ATC

calcipotriol, combinations; topical

2.4

57.5

397

1673

XQ848

NOMESCO Finland

Dermatological photography

3.1

57.0

245

808

R01AD58

ATC

fluticasone, combinations; nasal

1.5

57.0

2103

15072

R03DA04

ATC

theophylline; systemic, rectal

2.6

56.9

353

1415

R02

ICPC

Shortness of breath/dyspnoea

1.8

56.7

967

5694

N03AX16

ATC

[U] pregabalin

1.6

56.2

1419

9299

J01FA01

ATC

erythromycin; systemic

1.7

56.2

1169

7284

N06AX16

ATC

venlafaxine; oral

1.7

55.4

1156

7206

A92

ICPC

Allergy/allergic reaction NOS

2.4

55.3

383

1617

N06AX21

ATC

duloxetine; oral

1.8

55.2

900

5226

S01GX05

ATC

lodoxamide; ophthalmic

4.4

55.0

139

320

E0001A1, ,

ATC

2.9

54.3

258

901

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.3

53.5

206

636

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

5.4

52.8

104

194

D07AB09

ATC

triamcinolone; topical

6.9

52.3

119

D05AX02

ATC

calcipotriol; topical

2.8

51.7

264

959

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

5.5

51.4

181

A02BC01

ATC

omeprazole; systemic

1.5

51.2

1752

12301

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

51.0

733

4088

M02AA07

ATC

piroxicam; topical

1.5

50.5

2013

14596

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

5.9

50.4

153

J01FA06

ATC

roxithromycin; oral

1.5

50.3

2535

19267

S01GX04

ATC

nedocromil; ophthalmic

3.6

50.1

167

470

N05AA02

ATC

levomepromazine; systemic

2.6

49.9

308

1231

J01FA10

ATC

azithromycin; systemic

1.4

49.6

4477

37847

S97

ICPC

Chronic ulcer skin

2.3

49.6

379

1671

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

49.4

1757

12425

A01AB09

ATC

miconazole; local oral

2.0

49.0

585

3065

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

48.7

738

4183

S02

ICPC

Pruritus

2.4

48.7

352

1514

R06AE08, ,

ATC

4.8

48.6

110

232

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.2

48.4

193

609

N06AA09

ATC

amitriptyline; systemic

2.0

48.2

555

2872

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

47.7

558

2904

A02BC03

ATC

lansoprazole; oral

1.5

47.4

1641

11522

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

47.3

1755

12508

J02AC02

ATC

itraconazole; systemic

1.6

46.7

1120

7213

J30.19

ICD-10 Finland

Pollen allergy UNS

2.1

46.6

463

2270

J01MA02

ATC

ciprofloxacin; systemic

1.5

46.3

2343

17753

R01AC02

ATC

levocabastine; nasal

2.7

45.8

249

934

J01CF05

ATC

flucloxacillin; systemic

2.0

45.5

560

2963

L04AX03

ATC

methotrexate; systemic

1.8

44.9

679

3842

J02AB02

ATC

ketoconazole; oral

2.8

44.9

223

798

A02BC02

ATC

pantoprazole; systemic

1.4

44.8

4417

37594

N02BE01

ATC

paracetamol; systemic, rectal

1.6

44.4

6346

57836

R03BA08

ATC

ciclesonide; inhalant

1.9

44.3

619

3416

R06.0

ICD-10 Finland

Dyspnoea

1.5

44.1

1684

12047

L28.1

ICD-10 Finland

Prurigo nodularis

5.9

44.1

135

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

43.9

1575

11117

D07AC03

ATC

desoximetasone; topical

3.8

43.5

134

358

L08.0

ICD-10 Finland

Pyoderma

4.2

43.0

115

277

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

8.5

41.9

J01AA02

ATC

doxycycline; systemic

1.4

41.6

5082

44572

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.9

41.6

125

328

R01AD11

ATC

triamcinolone; nasal

1.9

41.4

596

3318

D06BX01

ATC

metronidazole; topical

1.8

41.2

736

4371

A01

ICPC

Pain general/multiple sites

1.8

41.2

706

4143

L17

ICPC

Foot/toe symptom/complaint

1.4

41.1

2095

15826

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

41.0

820

5027

N06AX03

ATC

mianserin; oral

2.3

40.8

314

1387

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

4.2

40.7

110

267

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.9

40.5

121

316

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

40.5

2217

16957

Z2446

NOMESCO Finland

Social worker

1.9

40.1

561

3095

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

40.0

1356

9436

A07DA03

ATC

loperamide; oral

2.8

40.0

202

730

S76

ICPC

Skin infection other

2.1

39.9

386

1871

D05BB02

ATC

acitretin; oral

3.2

39.7

162

519

A02BA02

ATC

ranitidine; systemic

1.6

39.5

1022

6687

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

39.3

2096

15939

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.7

39.2

210

782

N06AB03

ATC

fluoxetine; oral

1.7

39.1

856

5370

J01XC01

ATC

fusidic acid; systemic

3.9

38.5

114

296

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

38.3

456

2384

N02AA05

ATC

oxycodone; systemic

1.6

38.2

929

5984

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

37.8

363

1755

S18

ICPC

Laceration/cut

1.4

37.8

2948

23880

J01AA07

ATC

tetracycline; systemic

1.6

37.6

1086

7284

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

37.2

1110

7498

N05CF02

ATC

zolpidem; oral

1.6

36.9

1106

7480

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.1

36.7

157

517

A07AA02

ATC

nystatin; oral

2.1

36.6

346

1663

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

36.4

331

1567

N07BB01

ATC

disulfiram; oral

2.3

36.0

294

1332

A28

ICPC

Limited function/disability NOS

1.6

35.8

878

5660

H01.0

ICD-10 Finland

Blepharitis

1.8

35.8

562

3211

C07AA05

ATC

propranolol; systemic

1.5

35.7

1448

10429

F29

ICPC

Eye symptom/complaint other

1.7

35.6

782

4904

D07AB10

ATC

alclometasone; topical

6.6

35.6

A02BC05

ATC

esomeprazole; systemic

1.4

35.5

2466

19545

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

35.2

1380

9868

N05AF03

ATC

chlorprothixene; systemic

2.6

35.1

200

769

Z3226

NOMESCO Finland

Physiotherapist

1.5

33.9

1146

7941

V01AA05

ATC

tree pollen; parenteral

3.7

33.7

107

292

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

4.2

33.7

217

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

33.5

2141

16703

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.0

33.5

363

1835

UJF32

NOMESCO Finland

Coloscopy

1.5

33.3

1413

10250

WQ000

NOMESCO Finland

Hyposensibilisation

4.1

33.1

220

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.7

33.0

173

638

J01MA12

ATC

levofloxacin; systemic

1.5

32.7

1005

6819

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

32.5

3017

24924

E000008, ,

ATC

7.4

32.5

P29

ICPC

Psychological sympt/compl other

1.6

32.5

754

4792

Z2221

NOMESCO Finland

Medical doctor

1.4

32.4

1802

13723

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

32.3

406

2160

M79.6

ICD-10 Finland

Pain in limb

1.3

32.2

2975

24549

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

32.1

2697

21943

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

32.0

357

1823

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

32.0

310

1504

L85.3

ICD-10 Finland

Xerosis cutis

3.7

31.9

100

271

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

31.9

552

3244

R4110

NOMESCO Finland

Physiotherapy

1.4

31.7

1693

12793

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.2

31.7

127

403

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

31.6

567

3365

N05AH03

ATC

olanzapine; systemic

1.8

31.5

489

2782

L01

ICD-10 Finland

Impetigo

2.6

31.5

179

688

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

31.3

2722

22232

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

31.3

1333

9663

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

31.0

217

920

D05AX03

ATC

calcitriol; topical

3.6

31.0

101

281

XQ830

NOMESCO Finland

Exposure to foodstuff

7.3

30.8

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.0

30.8

139

473

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.2

30.7

198

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

5.4

30.5

112

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

30.4

1475

10944

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

30.3

630

3890

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

30.2

224

975

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

10.0

30.0

N02BF01

ATC

gabapentin; oral

1.7

29.7

645

4026

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

29.7

291

1418

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

29.5

497

2897

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

29.4

5451

49426

B00.5

ICD-10 Finland

Herpesviral ocular disease

6.3

29.4

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.0

29.3

131

443

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

29.2

2092

16550

A01AB04

ATC

amphotericin B; local oral

2.2

29.0

237

1074

N05BE01

ATC

buspirone; oral

2.4

29.0

210

904

P01AB01

ATC

metronidazole; oral, rectal

1.3

29.0

2593

21202

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

29.0

1869

14539

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

29.0

3281

27741

N03AE01

ATC

clonazepam; systemic

1.9

28.9

351

1846

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

5.5

28.8

100

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

28.8

958

6602

R03BC03

ATC

nedocromil; inhalant

1.9

28.4

389

2128

AA1AD

NOMESCO Finland

CT of head and brain

1.4

28.4

1505

11329

S02CA02

ATC

flumetasone and antiinfectives; otic

2.0

28.3

328

1697

N05AX08

ATC

risperidone; systemic

1.7

28.3

529

3173

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

27.9

124

418

R03CC03

ATC

terbutaline; systemic

2.1

27.9

268

1296

L29.8

ICD-10 Finland

Other pruritus

3.1

27.9

118

387

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

27.9

845

5706

L28

ICPC

Limited function/disability (L)

1.5

27.8

986

6879

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

27.8

181

743

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

27.8

290

1446

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

27.8

588

3646

J01MA14

ATC

moxifloxacin; systemic

1.7

27.7

511

3055

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

27.6

384

2111

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.7

27.5

153

582

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

8.6

27.4

A02BX02

ATC

sucralfate; oral

2.3

27.4

210

927

SPAT1260

SPAT

Consultation of another employee

1.5

27.3

1100

7870

R60.0

ICD-10 Finland

Localized oedema

1.6

27.3

695

4510

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

27.3

473

2779

F03

ICPC

Eye discharge

1.7

27.2

538

3277

N06AB06

ATC

sertraline; oral

1.5

27.2

870

5942

SPAT1301

SPAT

No procedures

1.4

27.1

1985

15725

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

27.0

334

1767

N05BA02

ATC

chlordiazepoxide; systemic

2.8

26.9

139

509

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

26.9

150

572

505

Kela drug reimbursment

Allergy to cow's milk in infants

6.0

26.7

ZXE00

NOMESCO Finland

One hour or less

1.3

26.7

2504

20553

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

26.5

471

2785

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

26.5

576

3594

N06AX12

ATC

bupropion; oral

1.6

26.5

627

3996

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

26.5

597

3761

EBA00

NOMESCO Finland

Extraction of tooth

1.3

26.4

2681

22246

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

26.2

876

6035

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

26.1

1636

12636

N06AX05

ATC

trazodone; oral

2.4

26.1

188

808

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

26.1

228

1063

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

26.0

852

5844

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

25.9

327

1743

ZY010

NOMESCO Finland

Hospital outpatient

1.7

25.9

446

2615

H18.6

ICD-10 Finland

Keratoconus

4.4

25.8

146

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

25.8

916

6389

J01FA09

ATC

clarithromycin; systemic

1.3

25.8

2034

16270

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

25.8

338

1824

M54.5

ICD-10 Finland

Low back pain

1.3

25.7

2490

20505

C07AB07

ATC

bisoprolol; oral

1.3

25.7

2425

19897

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

25.5

270

1353

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.3

25.5

188

816

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

25.4

1018

7267

SPAT1310

SPAT

Counselling related to known health issue

1.3

25.4

2110

16996

M02AA10

ATC

ketoprofen; topical

1.5

25.4

860

5938

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

25.4

1147

8377

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

25.2

123

437

K02.1

ICD-10 Finland

Caries of dentine

1.3

25.2

4438

39470

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

25.2

1271

9463

S01

ICPC

Pain/tenderness of skin

1.9

25.2

322

1723

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

25.2

1996

15967

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

25.1

422

2456

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.4

25.0

170

713

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

9.7

24.9

B01AB05

ATC

enoxaparin; parenteral

1.4

24.9

1672

13045

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

24.8

2804

23546

N03AG01

ATC

valproic acid; systemic, rectal

1.8

24.8

407

2354

-, ,

ICD-10 Finland

2.6

24.7

144

561

Z71.8

ICD-10 Finland

Other specified counselling

1.3

24.7

2508

20757

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

24.7

289

1502

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

24.6

3816

33349

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

24.6

713

4761

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

24.5

453

2708

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

24.5

677

4473

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

24.5

2144

17383

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

24.4

874

6103

J01DA08

ATC

[U] cefaclor

1.4

24.4

1037

7485

SPAT1229

SPAT

Assessment of need for aid

1.8

24.4

371

2098

WIX00

NOMESCO Finland

Allergy cleanup guidance

9.4

24.3

M48.0

ICD-10 Finland

Spinal stenosis

1.6

24.3

541

3395

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

24.3

1175

8680

N02BF02

ATC

pregabalin; oral

1.7

24.3

439

2609

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

24.3

266

1351

R97

ICPC

Allergic rhinitis

2.2

24.2

213

996

P15

ICPC

Chronic alcohol abuse

2.2

24.2

213

997

D01AE15

ATC

terbinafine; topical

1.8

24.1

385

2208

N03AF01

ATC

carbamazepine; oral, rectal

2.0

24.0

275

1418

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

24.0

219

1039

L03

ICPC

Low back symptom/complaint

1.3

24.0

2007

16159

S84

ICPC

Impetigo

3.7

24.0

208

R52.2

ICD-10 Finland

Other chronic pain

2.0

23.9

254

1275

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

23.9

2950

25016

S88

ICPC

Dermatitis contact/allergic

2.4

23.9

168

715

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.8

23.8

115

407

S01AA01

ATC

chloramphenicol; ophthalmic

1.8

23.7

346

1932

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

23.7

496

3065

L30.0

ICD-10 Finland

Nummular dermatitis

2.0

23.6

246

1227

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

23.6

541

3421

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

23.6

1181

8774

R03CC02

ATC

salbutamol; systemic

1.5

23.5

676

4504

N03AX09

ATC

lamotrigine; oral

1.7

23.5

398

2322

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.9

23.5

110

383

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

23.4

128

483

E66.8

ICD-10 Finland

Other obesity

1.7

23.4

409

2407

KMAK, ,

NOMESCO Finland

1.3

23.4

3529

30662

J01CF02

ATC

cloxacillin; systemic

2.7

23.4

128

484

A03FA02

ATC

cisapride; oral, rectal

1.8

23.3

391

2274

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

23.2

566

3633

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

23.1

107

370

WZC30

NOMESCO Finland

Teaching

1.5

23.0

921

6569

J01DA06

ATC

[U] cefuroxime

1.5

23.0

855

6012

D01AC03

ATC

econazole; topical

1.8

23.0

320

1761

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

22.9

177

785

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

22.9

148

607

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

22.8

307

1670

P76

ICPC

Depressive disorder

1.6

22.8

576

3728

S01XA18

ATC

ciclosporin; ophthalmic

3.9

22.7

170

ZXD05

NOMESCO Finland

Urgent procedure

1.3

22.6

1918

15450

F34.1

ICD-10 Finland

Dysthymia

1.9

22.6

276

1456

P01

ICPC

Feeling anxious/nervous/tense

1.4

22.5

1275

9661

U07

ICPC

Urine symptom/complaint other

1.6

22.5

498

3121

M04AA01

ATC

allopurinol; systemic

1.6

22.4

558

3596

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

3.4

22.4

232

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

22.4

582

3789

SPAT1058

SPAT

PEF monitoring instruction

1.7

22.4

465

2866

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

22.3

324

1805

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

3.7

22.3

195

A10BA02

ATC

metformin; oral

1.4

22.3

1392

10713

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

22.2

2660

22417

N06AB10

ATC

escitalopram; oral

1.3

22.1

1546

12101

ZXA05

NOMESCO Finland

Left side

1.4

22.1

1230

9292

R53

ICD-10 Finland

Malaise and fatigue

1.3

22.1

1750

13954

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

22.0

1547

12117

R05

ICPC

Cough

1.3

22.0

1743

13893

J01EA01

ATC

trimethoprim; systemic

1.3

22.0

1597

12569

N05CD02

ATC

nitrazepam; oral

3.1

22.0

295

N05AA01

ATC

chlorpromazine; systemic, rectal

3.2

22.0

270

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

21.9

5191

47465

G44.2

ICD-10 Finland

Tension-type headache

1.4

21.9

955

6917

C03DA01

ATC

spironolactone; oral

1.6

21.8

591

3886

D01AC08

ATC

ketoconazole; topical

3.1

21.7

292

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

21.7

389

2306

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

21.7

324

1822

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.3

21.7

252

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

21.6

104

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

7.7

21.6

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.1

21.4

279

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

21.4

188

879

S06

ICPC

Rash localized

1.8

21.4

355

2060

SPAT1254

SPAT

Administration of medicine

1.4

21.4

951

6911

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

21.3

2401

20048

T82

ICPC

Obesity

1.8

21.3

318

1787

K08.3

ICD-10 Finland

Retained dental root

1.7

21.3

418

2540

A97

ICPC

No disease

1.4

21.2

1386

10735

H01

ICPC

Ear pain/earache

1.4

21.1

976

7139

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

21.0

555

3628

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

20.9

780

5482

L60.0

ICD-10 Finland

Ingrowing nail

1.8

20.9

343

1983

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

20.8

2207

18273

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

20.8

581

3844

N05AB01

ATC

dixyrazine; systemic

3.4

20.8

219

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.5

20.7

200

D01AA02

ATC

natamycin; topical

2.4

20.7

142

598

SPAT1325

SPAT

Vaccination

1.3

20.7

1963

16018

50708

ICD-8 Finland

Hay fever, Alia definita

5.2

20.7

B00.11

ICD-10 Finland

Herpes simplex labialis

2.3

20.6

152

661

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

20.5

1043

7752

M01AH01

ATC

celecoxib; oral

1.4

20.5

883

6377

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

20.5

5243

48159

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

2.9

20.4

335

D12

ICPC

Constipation

2.0

20.4

230

1180

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

20.4

2536

21406

L50.0

ICD-10 Finland

Allergic urticaria

2.0

20.4

213

1064

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

20.4

574

3805

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

20.3

2543

21488

A04

ICPC

Weakness/tiredness general

1.4

20.2

1140

8618

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

20.2

476

3029

P99

ICPC

Psychological disorders other

1.9

20.2

266

1439

R52.9

ICD-10 Finland

Pain, unspecified

1.5

20.1

657

4494

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

20.1

616

4159

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.0

20.1

140

L12

ICPC

Hand/finger symptom/complaint

1.4

20.1

1204

9193

M79.7

ICD-10 Finland

Fibromyalgia

1.9

20.0

243

1279

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

20.0

1090

8194

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

20.0

510

3306

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

20.0

249

1323

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

20.0

895

6508

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

19.9

147

640

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

19.9

2919

25110

N02AC04

ATC

dextropropoxyphene; oral

2.2

19.9

166

761

SPAT1240

SPAT

Therapeutic discussion

1.4

19.9

850

6128

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

19.9

210

1054

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

19.8

175

821

N07BA03

ATC

varenicline; oral

1.8

19.8

307

1747

R03DC01

ATC

zafirlukast; oral

2.8

19.8

336

W19

ICD-10 Finland

Unspecified fall

1.5

19.7

609

4120

N06AA06

ATC

trimipramine; systemic

2.4

19.6

140

601

WXQ24

NOMESCO Finland

UVB/UVA light therapy

28.9

19.6

S24

ICPC

Hair/scalp symptom/complaint other

2.7

19.6

107

405

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.3

19.5

141

608

D05AA

ATC

Tars

4.2

19.4

122

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.3

19.4

214

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

19.3

617

4200

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.6

19.3

176

S06.0

ICD-10 Finland

Concussion

1.5

19.2

738

5213

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.0

19.2

277

J04AB02

ATC

rifampicin; systemic

3.1

19.0

252

R50.9

ICD-10 Finland

Fever, unspecified

1.4

19.0

1034

7769

N05AB03

ATC

perphenazine; systemic, rectal

2.0

18.8

212

1088

R05DB05

ATC

pentoxyverine; oral, rectal

2.0

18.8

194

966

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

6.3

18.8

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

6.3

18.8

SFA10

NOMESCO Finland

One-surface restoration

1.2

18.7

3970

35504

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

18.6

498

3263

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

18.5

319

1870

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

18.5

3731

33159

N06AA10

ATC

nortriptyline; systemic

2.3

18.5

133

573

T90

ICPC

Diabetes non-insulin dependent

1.4

18.4

1105

8426

R51.80

ICD-10 Finland

Headache

1.4

18.4

1162

8931

S01AA13

ATC

fusidic acid; ophthalmic

1.9

18.4

231

1230

S22

ICPC

Nail symptom/complaint

1.6

18.4

428

2714

SPAT1263

SPAT

Sampling

1.3

18.4

2772

23856

L50.3

ICD-10 Finland

Dermatographic urticaria

2.3

18.4

141

625

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

18.3

230

1225

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

18.3

789

5692

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

18.2

1365

10760

A06AC51

ATC

ispaghula, combinations; oral

1.8

18.2

260

1444

P16

ICPC

Acute alcohol abuse

2.4

18.2

121

504

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

2.6

18.1

100

381

L30.8

ICD-10 Finland

Other specified dermatitis

2.0

18.0

194

980

X58

ICD-10 Finland

Exposure to other specified factors

1.4

18.0

1011

7627

M03BX02

ATC

tizanidine; oral

1.2

18.0

3960

35481

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

18.0

708

5024

A10BJ06

ATC

semaglutide; parenteral

1.8

18.0

283

1618

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.8

17.9

321

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

17.8

655

4585

L01BC59

ATC

trifluridine, combinations; systemic

5.8

17.8

N05AD01

ATC

haloperidol; systemic

2.1

17.8

167

803

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.2

17.8

216

SPAT1255

SPAT

Intravenous administration of medicine

1.7

17.8

355

2167

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

20.0

17.7

L21.0

ICD-10 Finland

Seborrhoea capitis

2.9

17.6

296

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

17.6

1210

9416

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

17.6

1608

13017

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

17.6

1384

10981

S91

ICPC

Psoriasis

3.1

17.5

228

L04AX01

ATC

azathioprine; systemic

1.8

17.5

276

1579

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.4

17.4

L15

ICPC

Knee symptom/complaint

1.3

17.4

1526

12280

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

17.4

461

3014

-1, ,

NOMESCO Finland

1.3

17.3

2456

20952

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

17.3

349

J20

ICD-10 Finland

Acute bronchitis

1.5

17.3

644

4519

C05AA08

ATC

fluocortolone; rectal, topical

1.5

17.3

672

4754

S01XA02

ATC

retinol; ophthalmic

4.9

17.3

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

17.3

328

1976

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.2

17.3

144

661

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

17.2

1540

12422

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.0

17.2

177

880

R05DB20

ATC

other cough suppressants - combinations

1.7

17.2

337

2046

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

3.5

17.2

166

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

17.2

946

7111

V03AA01, ,

ATC

2.9

17.2

273

R35

ICD-10 Finland

Polyuria

1.7

17.2

341

2079

WX290

NOMESCO Finland

Other blockage of nerve

1.2

17.1

3616

32187

SPAT1262

SPAT

Handing over of treatment supplies

1.4

17.1

844

6230

R03BB01

ATC

ipratropium bromide; inhalant

2.0

17.1

178

889

H02AB09

ATC

hydrocortisone; systemic

2.0

17.1

178

889

SFA30

NOMESCO Finland

Three-surface restoration

1.2

17.1

2542

21794

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

17.1

215

1146

M01AE02

ATC

naproxen; oral, rectal

1.2

17.0

3923

35229

-50

ICPC

Medication/prescr/renewal

1.9

17.0

220

1184

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

17.0

554

3787

S07

ICPC

Rash generalized

3.6

17.0

158

S01AX11

ATC

[U] ofloxacin

2.0

17.0

182

919

N04AA02

ATC

biperiden; systemic

2.4

17.0

114

477

K07

ICPC

Swollen ankles/oedema

1.9

17.0

218

1171

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

16.9

108

441

D01BA02

ATC

terbinafine; oral

1.3

16.9

1332

10561

S01.0

ICD-10 Finland

Open wound of scalp

1.6

16.9

411

2635

L56.4

ICD-10 Finland

Polymorphous light eruption

4.2

16.8

105

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

16.8

575

3971

WQ064, ,

NOMESCO Finland

63.3

16.7

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

16.7

256

1452

A02BA04

ATC

nizatidine; systemic

1.7

16.7

335

2048

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

16.6

533

3630

A02BA03

ATC

famotidine; systemic

2.1

16.6

166

817

SFA20

NOMESCO Finland

Two-surface restoration

1.2

16.6

4087

36915

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

16.6

662

4708

G04BD12

ATC

mirabegron; oral

1.5

16.5

519

3520

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

7.0

16.5

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

16.5

2382

20342

B00.0

ICD-10 Finland

Eczema herpeticum

3.4

16.3

167

D01AC07

ATC

tioconazole; topical

2.0

16.3

171

858

J01AA04

ATC

lymecycline; systemic

1.4

16.2

937

7099

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

16.1

194

1020

WX002

NOMESCO Finland

Sedation and analgesia

1.4

16.1

964

7339

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

16.1

323

1974

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

16.1

615

4339

B05CB01

ATC

sodium chloride; irrigating solution

6.0

16.0

D11

ICPC

Diarrhoea

1.4

15.9

915

6924

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.2

15.9

195

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

15.9

190

997

M01AH02

ATC

rofecoxib; oral

1.5

15.9

538

3707

J01DB05

ATC

cefadroxil; oral

1.7

15.8

260

1505

G47.3

ICD-10 Finland

Sleep apnoea

1.3

15.8

1212

9567

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

15.8

1252

9927

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

15.8

544

3760

S71

ICPC

Herpes simplex

2.9

15.8

243

L40.8

ICD-10 Finland

Other psoriasis

3.3

15.7

176

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

15.7

792

5864

J01CA04

ATC

amoxicillin; systemic

1.3

15.7

6133

57999

A99

ICPC

Disease/condition unspecnature/site

1.4

15.7

625

4440

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

15.7

298

1797

S94

ICPC

Ingrowing nail

2.2

15.6

123

552

Z01.2

ICD-10 Finland

Dental examination

1.2

15.6

3448

30725

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

15.6

1514

12328

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

15.5

434

2872

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

15.5

217

1198

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

15.5

672

4849

H16.0

ICD-10 Finland

Corneal ulcer

1.7

15.5

313

1917

UKC02

NOMESCO Finland

Cystoscopy

1.4

15.5

703

5115

H10

ICD-10 Finland

Conjunctivitis

1.5

15.4

571

4003

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.4

15.4

164

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

15.3

660

4756

WZC00, ,

SPAT

1.3

15.3

1008

7783

L01BA01

ATC

methotrexate; systemic

1.9

15.3

201

1088

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

15.3

2420

20828

ZXA10

NOMESCO Finland

Bilateral

1.3

15.3

962

7377

P74

ICPC

Anxiety disorder/anxiety state

1.6

15.2

408

2674

G04BD08

ATC

solifenacin; oral

1.7

15.2

280

1674

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

16.0

15.2

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

15.2

436

2902

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

15.2

335

2099

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

15.2

779

5787

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.0

15.1

105

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

15.1

795

5931

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

15.0

448

3005

I50.0

ICD-10 Finland

Congestive heart failure

1.7

15.0

290

1755

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

15.0

1139

8974

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

15.0

425

2822

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

2.7

14.9

278

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.1

14.9

203

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

14.9

329

2062

S01AA02

ATC

chlortetracycline; ophthalmic

3.8

14.8

116

K59.0

ICD-10 Finland

Constipation

1.6

14.8

324

2027

N05AD03

ATC

melperone; systemic

2.9

14.7

236

R74

ICPC

Upper respiratory infection acute

1.2

14.7

2712

23689

N06AB05

ATC

paroxetine; oral

1.6

14.7

339

2148

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

14.6

343

2180

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

14.6

265

1578

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

6.1

14.6

V01AA02

ATC

grass pollen; parenteral

3.5

14.6

145

M01AX17

ATC

nimesulide; oral

1.3

14.6

1060

8298

L01

ICPC

Neck symptom/complaint

1.3

14.6

1084

8513

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

14.5

326

2050

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

14.5

1237

9896

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.3

14.5

111

493

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

14.5

4125

37561

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.8

14.5

244

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.4

14.5

101

431

H70

ICPC

Otitis externa

2.0

14.4

144

710

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

14.4

1027

8016

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

5.8

14.4

D19

ICPC

Teeth/gum symptom/complaint

1.2

14.4

2204

18876

ZXA00

NOMESCO Finland

Right side

1.3

14.4

1253

10049

N06AX26

ATC

vortioxetine; oral

1.4

14.4

568

4031

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

14.3

1800

15089

SDA03

NOMESCO Finland

Periodontal treatment

1.2

14.3

2767

24270

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

14.2

132

634

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

14.2

302

1876

T74.1

ICD-10 Finland

Physical abuse

2.0

14.2

155

790

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

14.2

188

1022

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

14.1

791

5956

L16

ICPC

Ankle symptom/complaint

1.4

14.1

819

6201

H29

ICPC

Ear symptom/complaint other

1.4

14.1

700

5169

A29

ICPC

General symptom/complaint other

1.4

14.1

761

5698

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

14.1

295

1825

G01AF04

ATC

miconazole; vaginal

1.7

14.1

252

1496

R01AC07

ATC

nedocromil; nasal

3.9

14.1

102

D01

ICPC

Abdominal pain/cramps general

1.3

14.1

919

7083

F73

ICPC

Eye infection/inflammation other

2.0

14.0

157

806

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

14.0

355

2297

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

14.0

290

1788

H16.9

ICD-10 Finland

Keratitis, unspecified

2.2

14.0

118

545

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.1

14.0

125

591

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

14.0

279

1705

L02

ICPC

Back symptom/complaint

1.4

13.9

725

5394

SPA47

NOMESCO Finland

Precision impression for denture

2.1

13.9

128

612

L08

ICPC

Shoulder symptom/complaint

1.3

13.9

1288

10407

U04

ICPC

Incontinence urine

1.7

13.8

271

1648

SBA00

NOMESCO Finland

Microbiological examinations

2.0

13.8

153

783

L13.0

ICD-10 Finland

Dermatitis herpetiformis

4.3

13.8

G04CA02

ATC

tamsulosin; oral

1.3

13.8

892

6866

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

13.8

782

5901

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

13.7

162

847

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

13.7

117

543

R5110, ,

SPAT

1.5

13.7

392

2607

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

13.7

147

744

P06

ICPC

Sleep disturbance

1.3

13.7

890

6854

P03

ICPC

Feeling depressed

1.3

13.7

874

6713

SPAT1284

SPAT

Extensive health certificate

1.8

13.6

194

1078

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.8

13.6

109

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

13.6

800

6068

Z08

ICPC

Social welfare problem

2.4

13.5

389

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

13.5

369

2432

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

13.4

696

5175

D10AF01

ATC

clindamycin; topical

1.6

13.4

278

1715

H60

ICD-10 Finland

Otitis externa

1.6

13.4

356

2330

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

13.4

312

1981

N05AL01

ATC

sulpiride; systemic

2.5

13.4

312

QDB10, ,

SPAT

2.1

13.4

122

582

R13

ICD-10 Finland

Dysphagia

1.6

13.3

355

2324

L04AC13

ATC

ixekizumab; parenteral

4.2

13.3

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.7

13.3

220

1277

F60.5

ICD-10 Finland

Anankastic personality disorder

2.4

13.3

397

A07AA09

ATC

vancomycin; oral

2.5

13.3

319

N06AB08

ATC

fluvoxamine; oral

2.0

13.2

136

678

L40

ICD-10 Finland

Psoriasis

2.1

13.2

123

591

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

13.2

293

1838

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

13.2

208

1191

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.2

333

2154

A10BJ02

ATC

liraglutide; parenteral

1.9

13.2

153

796

L13

ICPC

Hip symptom/complaint

1.3

13.2

960

7510

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

13.2

223

1304

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

13.2

479

3346

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.2

13.2

108

494

L86

ICPC

Back syndrome with radiating pain

1.6

13.1

339

2204

R52.0

ICD-10 Finland

Acute pain

1.7

13.1

224

1313

A08AB01

ATC

orlistat; oral

3.7

13.1

112

L29

ICD-10 Finland

Pruritus

2.1

13.1

115

541

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.8

13.1

186

1034

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

13.1

1453

11994

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

13.0

638

4699

R11

ICD-10 Finland

Nausea and vomiting

1.4

13.0

595

4332

UJH02

NOMESCO Finland

Anoscopy

1.8

13.0

201

1145

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

13.0

490

3446

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

13.0

104

471

T83

ICPC

Overweight

1.9

13.0

159

843

C08CA13

ATC

lercanidipine; oral

1.4

12.9

588

4277

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

12.9

360

2381

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.4

12.9

378

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

12.9

1959

16726

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

3.3

12.9

147

C08CA01

ATC

amlodipine; oral

1.2

12.9

1675

14067

N05AF01

ATC

flupentixol; systemic

2.5

12.9

330

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.7

12.9

243

X15

ICPC

Vaginal symptom/complaint other

1.6

12.9

340

2223

P18

ICPC

Medication abuse

2.9

12.9

210

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.9

12.9

210

SPAT1216

SPAT

Assessment of functional ability

1.4

12.8

696

5213

U05

ICPC

Urination problems other

1.7

12.8

250

1520

30041

ICD-8 Finland

Neuroses, Depressiva

2.9

12.8

200

D07AC04

ATC

fluocinolone acetonide; topical

11.5

12.8

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

12.7

245

1484

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

12.7

342

2245

C84.0

ICD-10 Finland

Mycosis fungoides

10.4

12.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

12.7

1017

8059

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

12.7

235

1409

L04AC10

ATC

secukinumab; parenteral

3.4

12.7

134

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.0

12.6

125

615

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.7

12.6

236

1418

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

5.1

12.6

-56

ICPC

Dressing/pressure/compress/tamponade

2.3

12.6

382

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

12.6

115

549

Z72.1

ICD-10 Finland

Alcohol use

2.4

12.6

334

C09CA06

ATC

candesartan; oral

1.3

12.6

1274

10398

SPAT1234

SPAT

Support of social functional capacity

1.7

12.5

247

1505

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

12.5

586

4284

L30

ICD-10 Finland

Other dermatitis

1.8

12.5

171

940

P19

ICPC

Drug abuse

2.3

12.5

378

M70.2

ICD-10 Finland

Olecranon bursitis

1.9

12.5

154

819

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.9

12.4

203

Z01.7

ICD-10 Finland

Laboratory examination

1.3

12.4

1030

8196

K70.1

ICD-10 Finland

Alcoholic hepatitis

3.9

12.4

VALMI, ,

NOMESCO Finland

1.2

12.4

1743

14756

V03AB30, ,

ATC

3.7

12.3

103

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

12.3

442

3081

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.8

12.3

210

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

12.3

263

1638

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

12.2

245

1499

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

12.2

119

582

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

5.3

12.2

N03AX11

ATC

topiramate; oral

1.8

12.2

175

975

N06AG02

ATC

moclobemide; oral

1.7

12.2

201

1167

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

12.2

433

3011

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

12.2

300

1931

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

12.2

864

6733

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

12.2

646

4821

N05AX12

ATC

aripiprazole; systemic

1.6

12.2

316

2059

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

12.1

479

3398

G04BD11

ATC

fesoterodine; oral

2.1

12.1

115

558

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

12.1

136

701

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

12.1

175

979

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

12.0

454

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

12.0

688

5195

A08

ICPC

Swelling

1.6

12.0

267

1678

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

12.0

220

1317

H13

ICPC

Plugged feeling ear

1.3

11.9

977

7759

N05BA12

ATC

alprazolam; oral

1.4

11.9

510

3670

WQ020, ,

NOMESCO Finland

13.3

11.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

11.9

393

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.7

11.8

220

M25.5

ICD-10 Finland

Pain in joint

1.2

11.8

2077

17970

-31

ICPC

Medical examin/health eval partial

1.5

11.8

385

2634

SPAT1202

SPAT

Intra-articular injection

2.0

11.7

127

646

D07BB01

ATC

flumetasone and antiseptics; topical

3.5

11.7

116

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

11.7

4759

44315

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

11.7

188

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

11.7

1479

12368

T78.3

ICD-10 Finland

Angioneurotic oedema

2.3

11.6

371

XKD00

NOMESCO Finland

Uroflowmetry

1.4

11.6

602

4474

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.4

11.6

SPAT1312

SPAT

General health counselling

1.2

11.6

2157

18755

WX704

NOMESCO Finland

Intubation

1.4

11.6

446

3150

A01AB10

ATC

natamycin; local oral

1.7

11.6

192

1118

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

11.5

179

1024

C07AB02

ATC

metoprolol; systemic

1.3

11.5

847

6635

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

11.4

1093

8850

SPAT1210

SPAT

Application of cast or individual aid

1.7

11.4

223

1358

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

11.4

124

633

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.2

11.4

439

M10.9

ICD-10 Finland

Gout, unspecified

1.6

11.3

271

1733

Z2445

NOMESCO Finland

Psychologist

1.5

11.3

307

2020

RS221, ,

NOMESCO Finland

2.2

11.3

433

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.6

11.3

254

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

11.3

446

3163

I84

ICD-10 Finland

Hemorrhoids

1.9

11.3

139

739

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.8

11.3

156

861

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

11.3

457

3258

UJD02

NOMESCO Finland

Gastroscopy

1.7

11.3

225

1377

N04BC05

ATC

pramipexole; oral

1.5

11.3

338

2273

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.0

11.2

155

L71.0

ICD-10 Finland

Perioral dermatitis

1.9

11.2

142

762

F01

ICPC

Eye pain

1.7

11.2

201

1197

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.9

11.2

140

749

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

11.2

316

2099

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.6

11.2

254

1606

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

11.2

505

3671

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

11.1

484

3493

SFA00

NOMESCO Finland

Small restoration

1.3

11.1

830

6508

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.6

11.1

288

1877

WX110, ,

SPAT

1.5

11.1

369

2534

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

11.1

386

2675

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.2

11.1

437

C09CA01

ATC

losartan; oral

1.3

11.1

1109

9028

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

3.9

11.0

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

8.0

11.0

R42

ICD-10 Finland

Dizziness and giddiness

1.3

11.0

1216

10012

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

11.0

518

3792

M01AB55

ATC

diclofenac, combinations; oral

1.6

10.9

266

1708

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

4.6

10.9

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.7

10.9

NHQ40

NOMESCO Finland

Amputation of toe

2.5

10.9

265

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

10.9

2342

20610

B02.9

ICD-10 Finland

Zoster without complication

1.5

10.9

319

2136

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.6

10.9

272

1759

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

10.8

245

1547

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

10.8

322

2162

WQ066, ,

NOMESCO Finland

15.5

10.8

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

10.8

731

5659

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

10.7

249

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

10.7

177

1030

M02AA15

ATC

diclofenac; topical

1.5

10.7

323

2175

SPAT1267

SPAT

Desensitisation

4.3

10.7

M01AC05

ATC

lornoxicam; systemic, rectal

21.4

10.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

10.7

899

7164

K08.80

ICD-10 Finland

Toothache NOS

1.4

10.6

593

4459

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.6

10.6

218

1344

F61

ICD-10 Finland

Mixed and other personality disorders

3.3

10.6

114

K03.00

ICD-10 Finland

Approximal wear

1.4

10.6

491

3584

-1, ,

ICPC

1.7

10.6

191

1139

M01AC06

ATC

meloxicam; systemic, rectal

1.2

10.6

1826

15740

R05

ICD-10 Finland

Cough

1.2

10.6

1304

10864

RS222, ,

NOMESCO Finland

2.3

10.6

324

L29

ICPC

Musculoskeletal sympt/complt other

1.4

10.6

502

3680

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

10.5

196

1178

Z00.0

ICD-10 Finland

General medical examination

1.3

10.5

1173

9662

JN4AD

NOMESCO Finland

Body CT examination

1.4

10.5

479

3485

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

10.5

522

3854

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.7

10.5

195

1172

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.5

10.5

258

L71.9

ICD-10 Finland

Rosacea, unspecified

1.8

10.5

156

881

R4190

NOMESCO Finland

Nutritional therapy

1.5

10.5

293

1942

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

10.5

277

1814

H16.2

ICD-10 Finland

Keratoconjunctivitis

2.8

10.5

189

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

10.5

1315

10977

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

10.4

500

3669

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.0

10.4

102

501

R06.2

ICD-10 Finland

Wheezing

1.5

10.4

280

1840

R95

ICPC

Chron obstructive pulmonary disease

1.9

10.4

119

618

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

10.4

654

5007

D07AC09

ATC

budesonide; topical

7.7

10.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.0

10.3

107

537

SPAT1252

SPAT

Overall medication plan or its review

1.5

10.3

276

1812

R01AD59

ATC

mometasone, combinations; nasal

1.4

10.3

488

3574

S10

ICPC

Boil/carbuncle

1.5

10.3

339

2324

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

4.2

10.3

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.1

10.3

205

Kela drug reimbursment

Chronic hypertension

1.3

10.3

1010

8201

RS311, ,

NOMESCO Finland

3.9

10.2

N06AX17

ATC

milnacipran; oral

2.5

10.2

249

RS340, ,

NOMESCO Finland

4.4

10.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

10.2

337

2312

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.9

10.2

164

F02

ICPC

Red eye

1.5

10.2

278

1833

A10BH01

ATC

sitagliptin; oral

1.4

10.2

370

2587

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.8

10.2

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.6

10.1

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

10.1

349

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

10.1

6423

61770

L30.4

ICD-10 Finland

Erythema intertrigo

2.2

10.1

375

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

2.9

10.1

165

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

3.1

10.1

128

J04BA02

ATC

dapsone; oral

3.2

10.1

123

D07XB01

ATC

flumetasone; topical

3.2

10.1

123

R06AX25

ATC

mizolastine; oral

3.9

10.1

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

10.1

175

1034

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

10.0

164

952

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

10.0

215

1341

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.5

10.0

246

D02BB01

ATC

betacarotene; oral

5.0

10.0

L90

ICPC

Osteoarthrosis of knee

1.5

10.0

265

1738

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

10.0

123

656

D09

ICPC

Nausea

1.4

10.0

383

2706

0540A

ICD-9 Finland

Herpes simplex, Eczema herpeticum

39.9

9.9

SPE90

NOMESCO Finland

Other partial denture

2.2

9.9

397

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.5

9.9

235

J01CF01

ATC

dicloxacillin; systemic

3.3

9.9

109

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.6

9.9

210

1306

U01

ICPC

Dysuria/painful urination

1.4

9.9

496

3667

SPD01

NOMESCO Finland

Mucosa-supported complete denture

2.7

9.9

184

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

9.8

490

3619

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

9.8

269

1775

A10AE04

ATC

insulin glargine; parenteral

1.4

9.8

445

3236

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

9.8

398

2839

N05AC02

ATC

thioridazine; oral

1.9

9.8

113

589

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

9.8

214

1341

RJ411, ,

NOMESCO Finland

3.3

9.8

105

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

9.8

1681

14467

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

9.8

201

1241

D01AE16

ATC

amorolfine; topical

1.4

9.8

511

3805

R10.0

ICD-10 Finland

Acute abdomen

1.7

9.8

190

1157

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

4.4

9.8

68408

ICD-8 Finland

Impetigo, Alia definita

8.7

9.7

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.3

9.7

292

SPAT1057

SPAT

Peak expiratory flow measurement

1.9

9.7

120

640

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

9.7

1551

13254

K85

ICPC

Elevated blood pressure

1.3

9.7

712

5568

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

9.7

285

1912

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

9.6

149

852

N30.0

ICD-10 Finland

Acute cystitis

1.2

9.6

1062

8733

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

2.7

9.6

192

B82

ICPC

Anaemia other/unspecified

1.8

9.6

143

809

U02

ICPC

Urinary frequency/urgency

1.3

9.6

853

6840

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

9.6

301

2047

WQ021, ,

NOMESCO Finland

8.3

9.5

E87.6

ICD-10 Finland

Hypokalaemia

1.7

9.5

155

900

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.6

9.5

216

1368

WX892

NOMESCO Finland

Monitored bed care

1.4

9.5

367

2597

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

9.5

2003

17559

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

4.0

9.5

U13

ICPC

Bladder symptom/complaint other

1.8

9.5

149

857

R78

ICPC

Acute bronchitis/bronchiolitis

1.9

9.4

112

590

M01CB03

ATC

auranofin; oral

3.1

9.4

123

H03AA01

ATC

levothyroxine sodium; systemic

1.2

9.4

1240

10393

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

9.4

216

1371

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

9.4

180

1092

Z94.7

ICD-10 Finland

Corneal transplant status

4.1

9.4

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

9.4

390

2795

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

9.4

220

1404

L21

ICD-10 Finland

Seborrhoeic dermatitis

1.9

9.3

110

578

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

9.3

297

2025

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.5

9.3

213

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.6

9.3

190

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

9.3

154

899

H62.0

ICD-10 Finland

Otitis externa in bacterial diseases classified elsewhere

4.9

9.3

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

9.3

202

1266

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

9.2

644

5002

M01AE51

ATC

ibuprofen, combinations; systemic

2.3

9.2

293

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.2

912

7407

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.2

328

2286

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

9.2

351

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

9.2

324

2254

R03AK11

ATC

formoterol and fluticasone; inhalant

1.8

9.2

133

747

H60.8

ICD-10 Finland

Other otitis externa

1.6

9.2

186

1146

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

9.2

400

2892

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

9.1

298

2041

J05AH02

ATC

oseltamivir; oral

2.6

9.1

186

G04BD07

ATC

tolterodine; oral

1.6

9.1

183

1124

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

9.1

673

5270

H04

ICPC

Ear discharge

1.7

9.1

168

1010

SPAT1101

SPAT

Orthostatic test

1.7

9.1

156

920

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

9.1

244

1606

JN4BD

NOMESCO Finland

Extensive body CT

1.4

9.1

410

2982

K90.0

ICD-10 Finland

Coeliac disease

1.7

9.1

164

981

XQ820

NOMESCO Finland

Exposure to medicinal substance

3.1

9.0

121

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

9.0

193

1205

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.2

9.0

341

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

9.0

456

3379

F05.9

ICD-10 Finland

Delirium, unspecified

2.0

9.0

434

B86

ICD-10 Finland

Scabies

1.6

9.0

214

1371

Z51.5

ICD-10 Finland

Palliative care

1.5

9.0

318

2215

L84

ICPC

Back syndrome without radiat pain

1.5

8.9

272

1838

B01AA03

ATC

warfarin; systemic

1.3

8.9

703

5551

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.9

8.9

138

J01MA06

ATC

norfloxacin; oral

1.3

8.9

605

4683

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

7.4

8.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

8.9

519

3931

Z01

ICPC

Poverty/financial problem

3.1

8.9

117

H92.0

ICD-10 Finland

Otalgia

1.4

8.8

444

3285

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

1.8

8.8

135

770

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

8.8

732

5816

SCA02

NOMESCO Finland

Preventive oral health care

1.3

8.8

850

6878

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

3.2

8.8

102

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.7

8.8

158

942

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.8

8.8

119

654

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

8.8

562

4311

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.5

8.8

260

1746

S08

ICPC

Skin colour change

1.5

8.7

272

1846

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.7

8.7

166

1006

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

8.7

327

2301

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.4

8.7

232

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1.9

8.7

109

585

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

1.9

8.7

515

SPAT1360

SPAT

Extensive global examination

1.4

8.7

328

2311

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

8.7

535

4084

EB1AA, ,

SPAT

1.4

8.7

371

2673

WX402

NOMESCO Finland

General anaesthesia

1.2

8.7

1337

11376

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

8.7

169

1031

R4120

NOMESCO Finland

Occupational therapy

1.4

8.7

356

2547

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

14.0

8.7

3073, ,

Kela drug reimbursment

50.0

8.7

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.6

8.7

170

1039

R52.1

ICD-10 Finland

Chronic intractable pain

2.4

8.6

233

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

8.6

161

971

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.5

8.6

245

1632

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

8.6

712

5655

L40.4

ICD-10 Finland

Guttate psoriasis

3.1

8.6

114

G50.1

ICD-10 Finland

Atypical facial pain

1.9

8.6

503

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

8.6

212

1369

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.6

3803

35236

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

8.6

594

4610

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.5

8.6

254

1707

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

8.6

309

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

4.4

8.6

RD210, ,

NOMESCO Finland

1.8

8.6

126

711

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.6

8.6

180

1119

SPAT1247

SPAT

Outpatient detoxication and monitoring

3.3

8.6

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.8

8.6

117

646

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.1

8.6

388

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

8.5

139

808

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.6

8.5

175

1082

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.4

8.5

247

SPAT1285

SPAT

Provision of consultation response

1.5

8.5

272

1857

K11.70

ICD-10 Finland

Hypoptyalism

3.0

8.5

115

RS121, ,

NOMESCO Finland

2.5

8.5

199

N05AF05

ATC

zuclopenthixol; systemic

2.5

8.5

199

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

2.5

8.5

211

C10AC01

ATC

colestyramine; oral

1.7

8.5

137

795

H16.8

ICD-10 Finland

Other keratitis

3.8

8.5

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

27.5

8.5

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

2.0

8.5

410

D10AX03

ATC

azelaic acid; topical

1.3

8.5

541

4153

C08CA02

ATC

felodipine; oral

1.4

8.5

340

2424

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

8.4

236

1567

A98

ICPC

Health maint/preventive medicine

1.4

8.4

7267

71167

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.9

8.4

102

542

SPAT1281

SPAT

Other administrative function

1.4

8.4

440

3277

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.5

8.4

246

1649

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

8.4

165

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

8.4

122

686

H26.02

ICD-10 Finland

Presenil cataract

1.8

8.4

118

657

C84.1

ICD-10 Finland

Sézary disease

90.0

8.4

L04

ICPC

Chest symptom/complaint

1.4

8.4

361

2604

SPAT1251

SPAT

Organisation of medication

1.6

8.4

164

1002

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.0

8.4

398

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

8.4

114

629

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.2

8.4

306

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

8.4

1275

10835

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

8.3

254

1717

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

4.9

8.3

H10.2

ICD-10 Finland

Other acute conjunctivitis

1.9

8.3

502

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

3.1

8.3

106

WX213

NOMESCO Finland

Lower leg blockade

2.5

8.3

201

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

2.3

8.3

256

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

3.7

8.3

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

8.3

1617

14052

A07EB01

ATC

cromoglicic acid; oral

10.7

8.3

R05CB03

ATC

carbocisteine; oral

1.9

8.3

105

567

F22.0

ICD-10 Finland

Delusional disorder

2.1

8.2

347

N05AN01

ATC

lithium; oral

1.7

8.2

144

855

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

3.8

8.2

R06.5

ICD-10 Finland

Mouth breathing

1.3

8.2

485

3682

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.2

8.2

962

7963

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

8.1

100

534

WQ007, ,

NOMESCO Finland

6.5

8.1

A01AC01

ATC

triamcinolone; local oral

2.1

8.1

329

SAA04

NOMESCO Finland

Special examination of mouth

1.4

8.1

336

2407

RS230, ,

NOMESCO Finland

3.0

8.1

118

K50.9

ICD-10 Finland

Crohn disease, unspecified

1.9

8.1

485

L20

ICPC

Joint symptom/complaint NOS

1.5

8.1

214

1403

H60.1

ICD-10 Finland

Cellulitis of external ear

2.0

8.1

389

M03BX01

ATC

baclofen; systemic

1.9

8.1

104

563

M54.3

ICD-10 Finland

Sciatica

1.5

8.1

287

1999

A27

ICPC

Fear of other disease NOS

1.5

8.1

260

1777

M79.1

ICD-10 Finland

Myalgia

1.2

8.1

931

7686

NG1DA

NOMESCO Finland

X-ray of knees

2.0

8.1

417

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

8.1

407

3014

D06BB06

ATC

penciclovir; topical

3.6

8.1

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

2.8

8.1

135

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.3

8.0

241

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

3.2

8.0

QXB99, ,

SPAT

1.7

8.0

126

726

S22.3

ICD-10 Finland

Fracture of rib

1.4

8.0

331

2374

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

8.0

308

2181

D06

ICPC

Abdominal pain localized other

1.3

8.0

579

4524

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.9

529

4084

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

7.9

169

1055

N05AC01

ATC

periciazine; systemic

3.5

7.9

RF220, ,

NOMESCO Finland

2.1

7.9

313

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

7.9

151

917

M71.0

ICD-10 Finland

Abscess of bursa

2.9

7.9

120

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

1.8

7.9

109

604

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

7.9

492

3763

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

7.9

266

1836

-54

ICPC

Repair/fix-suture/cast/prosth device

1.9

7.9

100

540

F32.1

ICD-10 Finland

Moderate depressive episode

1.3

7.9

450

3398

A07EA06

ATC

budesonide; oral, local oral

1.5

7.9

206

1350

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

3.9

7.8

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

2.2

7.8

282

B07.9

ICD-10 Finland

Verruca simplex

1.5

7.8

236

1593

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.2

7.8

263

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.1

7.8

341

A10BH05

ATC

linagliptin; oral

1.6

7.8

179

1138

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

7.8

496

3805

A12BA01

ATC

potassium chloride; oral

1.7

7.8

148

898

K07.60

ICD-10 Finland

Snapping jaw

1.4

7.8

339

2452

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

3.2

7.8

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.6

7.8

178

1132

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

1.8

7.8

105

579

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

3.3

7.7

L91

ICPC

Osteoarthrosis other

2.0

7.7

410

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

7.7

226

1516

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

7.7

383

A10BX01

ATC

guar gum; oral

1.7

7.7

134

794

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

7.7

141

847

S80.0

ICD-10 Finland

Contusion of knee

1.3

7.7

480

3671

WW200

NOMESCO Finland

Immunization

1.7

7.7

148

901

A91

ICPC

Abnormal result investigation NOS

1.4

7.7

271

1887

S20

ICPC

Corn/callosity

1.9

7.7

453

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

2.2

7.7

259

N06BA04

ATC

methylphenidate; oral

1.4

7.7

344

2501

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

4.3

7.6

L63.0

ICD-10 Finland

Alopecia (capitis) totalis

5.9

7.6

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

7.6

346

2520

N01BB20

ATC

amides - combinations; parenteral

2.1

7.6

318

G01AF05

ATC

econazole; vaginal

1.4

7.6

364

2674

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

4.5

7.6

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.5

7.6

218

1457

R55

ICD-10 Finland

Syncope and collapse

1.3

7.6

515

3986

Z09

ICPC

Legal problem

2.8

7.6

134

XQ858, ,

SPAT

2.8

7.6

123

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.9

7.6

455

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

7.6

1308

11238

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

7.5

209

1388

6840A

ICD-9 Finland

Impetigo[IMPETIGO CONTAGIOSA]

8.8

7.5

L63.9

ICD-10 Finland

Alopecia areata, unspecified

2.4

7.5

199

S01AA03

ATC

neomycin; ophthalmic

2.5

7.5

181

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.4

7.5

389

2896

M01AH05

ATC

etoricoxib; oral

1.1

7.5

3751

34913

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

7.5

218

1462

L04AA32

ATC

apremilast; oral

3.8

7.5

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

7.5

680

5465

F32

ICD-10 Finland

Depressive episode

1.4

7.5

365

2691

IHZ05, ,

SPAT

1.4

7.5

387

2880

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

7.5

834

6861

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.7

7.5

119

689

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

7.5

233

1585

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

7.5

461

3523

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

2.7

7.5

141

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

1.9

7.4

437

N39.3

ICD-10 Finland

Stress incontinence

1.4

7.4

332

2412

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

4.2

7.4

L73.8

ICD-10 Finland

Other specified follicular disorders

2.0

7.4

348

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

7.4

104

580

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.4

143

872

R5599

NOMESCO Finland

Other rehabilitation service

1.6

7.4

147

903

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.4

7.4

298

2127

OAB50, ,

SPAT

1.4

7.4

375

2782

M54

ICD-10 Finland

Dorsalgia

1.2

7.4

776

6342

KGH10

NOMESCO Finland

Operation for phimosis

1.7

7.4

130

774

-59

ICPC

Other therap proced/minor surg NEC

1.7

7.4

124

729

WYA30, ,

SPAT

2.4

7.4

207

S99

ICPC

Skin disease other

1.8

7.4

112

640

C10AA01

ATC

simvastatin; oral

1.2

7.4

1545

13494

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.7

7.4

125

737

K85

ICD-10 Finland

Acute pancreatitis

2.1

7.4

316

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

7.4

1057

8924

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

3.4

7.4

E66

ICD-10 Finland

Obesity

1.4

7.3

343

2511

XQ855, ,

SPAT

2.1

7.3

290

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.0

7.3

391

M01AB01

ATC

indometacin; systemic, rectal

1.4

7.3

266

1864

B02.3

ICD-10 Finland

Zoster ocular disease

3.7

7.3

IGY02, ,

SPAT

1.7

7.3

113

649

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

7.3

600

4763

F05

ICPC

Visual disturbance other

1.6

7.3

175

1125

I50

ICD-10 Finland

Heart failure

1.8

7.3

100

554

S01KA02

ATC

hypromellose; ophthalmic

2.0

7.3

344

S92.5

ICD-10 Finland

Fracture of other toe

1.6

7.3

174

1118

ZX120, ,

SPAT

2.1

7.3

331

SPAT1139

SPAT

Nutrition survey

1.6

7.3

158

993

90494, ,

NOMESCO Finland

9.3

7.3

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.6

7.2

168

1072

L04AC16

ATC

guselkumab; systemic

4.1

7.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

7.2

398

2990

WVA20, ,

SPAT

1.5

7.2

188

1231

P17

ICPC

Tobacco abuse

1.9

7.2

442

R49.01

ICD-10 Finland

Functional dysphonia

1.6

7.2

149

925

S19

ICPC

Skin injury other

1.5

7.2

206

1377

SPA51

NOMESCO Finland

Determination of bite and dental arch location, demanding

2.4

7.2

197

A10BB12

ATC

glimepiride; oral

1.5

7.2

221

1499

S02AA03

ATC

boric acid; otic

2.4

7.2

185

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.8

7.2

535

369

Kela drug reimbursment

Regorafenib

4.3

7.2

A10BX07

ATC

[U] liraglutide

2.3

7.2

222

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

7.2

703

5700

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

7.2

106

601

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

7.2

305

2199

M70.4

ICD-10 Finland

Prepatellar bursitis

1.8

7.2

500

3029

Kela drug reimbursment

Upadacitinib

3.0

7.1

100

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

4.5

7.1

R04

ICPC

Breathing problem other

1.5

7.1

200

1331

G03CA04

ATC

estriol; systemic, vaginal

1.5

7.1

198

1315

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

1.8

7.1

100

558

N06AX22

ATC

agomelatine; oral

1.6

7.1

155

974

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

7.1

624

4992

K03.28

ICD-10 Finland

Other erosion of teeth

1.6

7.1

162

1029

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

7.1

212

1429

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

7.1

323

2354

NFS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of hip or thigh

20.0

7.1

SGA01

NOMESCO Finland

Emergency treatment

1.2

7.1

1033

8730

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

7.1

507

3953

SPAT1153

SPAT

Removal of sutures

1.2

7.1

1511

13209

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

2.3

7.1

217

B80

ICPC

Iron deficiency anaemia

1.6

7.1

158

999

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

1.6

7.1

165

1054

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

2.9

7.1

106

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

12.0

7.1

30180

ICD-8 Finland

Personality disorders, Immatura

3.8

7.0

S01AA12

ATC

tobramycin; ophthalmic

3.8

7.0

D18

ICPC

Change in faeces/bowel movements

1.6

7.0

144

892

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.5

7.0

175

N02CX04, ,

ATC

1.9

7.0

432

OAB42, ,

SPAT

1.2

7.0

831

6880

D07BA01

ATC

prednisolone and antiseptics; topical

10.0

7.0

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.0

7.0

363

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.4

7.0

250

1747

SPAT1243

SPAT

Psychiatric/psychological examination

1.5

7.0

207

1394

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.5

7.0

193

1281

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

7.0

516

4042

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

7.0

268

1898

Z04

ICD-10 Finland

Examination and observation for other reasons

1.9

7.0

426

XKC03

NOMESCO Finland

Water cystometry

1.7

7.0

124

741

N06AX18

ATC

reboxetine; oral

2.2

7.0

257

C09AA02

ATC

enalapril; systemic

1.2

7.0

738

6037

X57

ICD-10 Finland

Unspecified privation

1.7

7.0

118

696

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

7.0

567

4498

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

2.5

7.0

170

A03

ICPC

Fever

1.2

6.9

1325

11476

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

1.9

6.9

399

49309

ICD-8 Finland

Asthma, Unspecified

4.4

6.9

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

1.9

6.9

406

D11AH04

ATC

alitretinoin; oral

6.3

6.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

6.8

343

2541

C10AA05

ATC

atorvastatin; oral

1.2

6.8

1751

15527

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.8

327

2405

H60.3

ICD-10 Finland

Other infective otitis externa

1.7

6.8

128

776

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

2.0

6.8

353

SPE02

NOMESCO Finland

Metal-framed partial denture

2.0

6.8

374

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.8

120

716

K30

ICD-10 Finland

Functional dyspepsia

1.3

6.8

626

5040

SBB10

NOMESCO Finland

Dental impressions

1.3

6.8

532

4199

N06AA04

ATC

clomipramine; systemic

1.9

6.8

416

A85

ICPC

Adverse effect medical agent

2.1

6.8

273

176

Kela drug reimbursment

Regorafenib

4.1

6.8

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

6.8

316

2315

05405

ICD-8 Finland

Herpes simplex, Kerato-conjunctivitis herpetica

9.3

6.8

G43.9

ICD-10 Finland

Migraine, unspecified

1.3

6.8

450

3477

S09

ICPC

Infected finger/toe

1.6

6.7

165

1067

D11AH08

ATC

abrocitinib; oral

39.9

6.7

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1.8

6.7

474

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

6.7

806

6680

05403

ICD-8 Finland

Herpes simplex, Cutaneus (Eczema herpeticum)

16.7

6.7

F93.80

ICD-10 Finland

Generalized anxiety in the bardom age

4.2

6.7

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

6.7

496

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.0

6.7

355

E86

ICD-10 Finland

Volume depletion

1.8

6.7

102

584

Z50.5

ICD-10 Finland

Speech therapy

1.8

6.7

511

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.7

144

904

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

1.8

6.7

504

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1.8

6.7

497

M15.8

ICD-10 Finland

Other polyarthrosis

1.9

6.7

454

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

6.7

325

2398

2920A

ICD-9 Finland

Drug psychoses, Drug withdrawal syndrome

22.5

6.7

Z72.2

ICD-10 Finland

Drug use

2.3

6.7

217

29599

ICD-8 Finland

Schizophrenia, Unspecified type

3.4

6.7

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.6

6.7

158

1015

N02AJ13

ATC

tramadol and paracetamol; systemic

1.7

6.7

106

615

K92.1

ICD-10 Finland

Melaena

1.5

6.7

221

1524

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

6.7

199

1344

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

3.3

6.7

160

Kela drug reimbursment

exenatide

1.9

6.7

405

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.4

6.6

234

1632

I45.0

ICD-10 Finland

Right fascicular block

2.8

6.6

110

WZB00, ,

SPAT

1.2

6.6

787

6516

-44

ICPC

Preventive immunization/medic

1.3

6.6

363

2727

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.5

6.6

162

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

6.6

285

2061

B37.08

ICD-10 Finland

Other candidal stomatitis

2.3

6.6

199

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.6

412

5308

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

6.6

181

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

1.8

6.6

471

NG1AD

NOMESCO Finland

Knee CT examination

1.9

6.6

386

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.6

6.5

135

839

EB1SA, ,

SPAT

1.4

6.5

320

2363

K76.89

ICD-10 Finland

Other specified diseases of liver

3.2

6.5

L41.9

ICD-10 Finland

Parapsoriasis, unspecified

10.0

6.5

B05BB01

ATC

electrolytes; parenteral

3.8

6.5

A11

ICPC

Chest pain NOS

1.3

6.5

394

3006

R5140, ,

SPAT

2.1

6.5

265

D97

ICPC

Liver disease NOS

2.8

6.5

106

E66.0

ICD-10 Finland

Obesity due to excess calories

2.2

6.5

239

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.4

6.5

288

2094

M01AX05

ATC

glucosamine; oral

1.2

6.5

656

5342

M01AX01

ATC

nabumetone; oral

1.6

6.5

155

999

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.6

6.4

156

1007

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.4

6.4

266

1910

A10BJ05

ATC

dulaglutide; parenteral

1.8

6.4

467

L28.2

ICD-10 Finland

Other prurigo

3.1

6.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

6.4

135

843

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

6.4

202

1379

SPAT1097

SPAT

Recording of ECG

1.3

6.4

577

4633

A03BB01

ATC

butylscopolamine; systemic, rectal

3.9

6.4

F60.8

ICD-10 Finland

Other specific personality disorders

2.3

6.4

202

A08AA01

ATC

phentermine; oral

3.4

6.4

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

3.4

6.4

QDH01

NOMESCO Finland

Excision of nail bed in toe

3.3

6.4

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

3.3

6.4

S01AA30

ATC

combinations of different antibiotics; ophthalmic

2.1

6.4

267

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.6

6.4

131

814

R80

ICD-10 Finland

Isolated proteinuria

2.3

6.4

190

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.7

6.4

564

F71

ICPC

Conjunctivitis allergic

3.0

6.3

B35.4

ICD-10 Finland

Tinea corporis

1.9

6.3

426

L29.2

ICD-10 Finland

Pruritus vulvae

1.7

6.3

108

639

K04.08

ICD-10 Finland

Other specified pulpit

1.3

6.3

515

4085

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.0

6.3

342

R05DA09

ATC

dextromethorphan; oral

2.0

6.3

342

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.4

6.3

223

1556

3006

Kela drug reimbursment

Baricitinib

3.7

6.3

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

2.4

6.3

178

K29.2

ICD-10 Finland

Alcoholic gastritis

4.0

6.3

WGA11

NOMESCO Finland

Planning of pain management

2.6

6.3

136

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.7

6.3

103

602

L50.5

ICD-10 Finland

Cholinergic urticaria

6.5

6.3

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.7

6.3

115

693

S70.0

ICD-10 Finland

Contusion of hip

1.5

6.3

180

1205

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.6

6.3

121

739

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.3

329

G53.0

ICD-10 Finland

Postzoster neuralgia

2.8

6.3

108

NFU00

NOMESCO Finland

Removal of partial prosthesis from hip joint, other or unspecified

9.2

6.3

M01AH03

ATC

valdecoxib; oral

1.4

6.3

236

1668

N05AH02

ATC

clozapine; systemic

1.7

6.3

107

634

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

2.6

6.3

131

9700/3-C44.9

ICD-O-3

Mycosis fungoides of skin, NOS

18.0

6.3

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

6.3

732

6053

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.5

6.2

184

1240

A06AC07

ATC

triticum (wheat fibre); oral

3.8

6.2

A02BB01

ATC

misoprostol; oral

2.9

6.2

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.5

6.2

143

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

6.2

103

605

SPAT1059

SPAT

Spirometry at the office

1.5

6.2

213

1479

Z29

ICPC

Social problem NOS

1.6

6.2

144

921

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

6.2

123

758

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

6.2

114

689

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

1.7

6.2

107

636

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

6.2

151

978

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

2.5

6.2

138

A07EC02

ATC

mesalazine; oral, rectal

1.4

6.1

282

2062

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.5

6.1

168

1115

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.8

6.1

496

D06AX07

ATC

gentamicin; topical

5.3

6.1

OAA80, ,

SPAT

0.8

6.1

447

5643

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

6.1

298

2200

R20.2

ICD-10 Finland

Paraesthesia of skin

1.3

6.1

402

3102

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.5

6.1

164

1084

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

6.1

163

1076

30188

ICD-8 Finland

Personality disorders, Alia definita

3.2

6.1

S04

ICPC

Lump/swelling localized

1.2

6.1

665

5457

CG2S4

NOMESCO Finland

Photography of cornea

3.3

6.1

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

6.1

194

1328

C10AX09

ATC

ezetimibe; oral

1.2

6.1

651

5332

A10BK03

ATC

empagliflozin; oral

1.3

6.1

397

3061

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.8

6.1

425

M54.1

ICD-10 Finland

Radiculopathy

1.5

6.1

187

1272

S00.0

ICD-10 Finland

Superficial injury of scalp

1.6

6.1

116

708

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

6.1

265

1922

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.0

6.1

327

L71.8

ICD-10 Finland

Other rosacea

1.8

6.1

513

D83

ICPC

Mouth/tongue/lip disease

1.9

6.0

369

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.7

6.0

111

671

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.4

6.0

239

1705

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.7

6.0

112

679

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.2

6.0

614

5003

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

1130

5283

2.33

133.30

1.6

1.3

1459.40

183.30

u/ml

14.78

1076

4933

(3006315) Basophils [#/volume] in Blood

4410

34111

1.68

103.54

7.8

6.8

0.04

e9/l

3.02

3857

29531

(3001604) Monocytes [#/volume] in Blood

4403

34056

1.68

103.26

7.8

6.7

0.58

0.56

e9/l

7.99

3851

29500

(3013115) Eosinophils [#/volume] in Blood

4521

35228

1.68

102.93

8.1

7.0

0.24

0.19

e9/l

28.34

4036

31003

(3019198) Lymphocytes [#/volume] in Blood

4491

35022

1.68

101.08

7.8

6.8

1.99

e9/l

0.07

4027

31103

(3013650) Neutrophils [#/volume] in Blood by Automated count

4755

37845

1.67

96.94

11.5

9.7

4.16

4.02

e9/l

3.53

4181

32858

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

156

266

5.96

87.05

1.4

1.2

9.74

10.67

u/ml

0.08

125

188

(3010726) Horse dander IgE Ab [Units/volume] in Serum

514

2034

2.63

85.53

1.2

1.1

5.23

1.98

u/ml

6.36

386

1111

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

560

2383

2.45

79.89

1.2

1.1

3.74

2.63

u/ml

1.29

400

1326

(3019069) Monocytes/Leukocytes in Blood

3988

31406

1.56

76.13

8.0

7.0

8.62

8.55

0.81

3802

29650

(3003888) Timothy IgE Ab [Units/volume] in Serum

505

2097

2.50

75.87

1.2

1.1

7.34

5.85

u/ml

1.18

374

1223

(3006504) Eosinophils/Leukocytes in Blood

3978

31351

1.55

75.37

7.9

6.9

3.35

2.82

29.07

3782

29562

(3022096) Basophils/Leukocytes in Blood

3969

31315

1.55

74.44

8.0

7.0

0.67

0.68

0.30

3768

29498

(3002030) Lymphocytes/Leukocytes in Blood

4079

32532

1.54

71.69

7.9

6.8

28.21

29.37

9.92

3905

31033

(3027231) Wheat IgE Ab [Units/volume] in Serum

132

232

5.76

71.39

1.3

1.1

11.11

4.74

u/ml

0.50

126

215

(3008401) Mugwort IgE Ab [Units/volume] in Serum

482

2022

2.47

70.75

1.2

1.1

2.65

1.08

u/ml

2.69

340

984

(3024561) Albumin [Mass/volume] in Serum or Plasma

3395

26150

1.53

69.19

6.1

5.2

35.98

36.48

g/l

5.80

3214

24627

(3023368) Bacteria identified in Blood by Culture

2206

15428

1.60

69.06

5.2

4.2

—

(3018418) pH of Serum or Plasma

2391

17089

1.58

67.99

4.2

4.1

7.40

0.56

1710

12022

(3014133) Dog dander IgE Ab [Units/volume] in Serum

427

1732

2.55

67.27

1.1

12.82

4.11

u/ml

6.90

321

911

(3018010) Neutrophils/Leukocytes in Blood

3994

31985

1.51

66.86

7.7

6.7

56.64

56.14

1.92

3874

30709

(3012494) Peanut IgE Ab [Units/volume] in Serum

154

338

4.62

64.72

1.2

12.41

13.57

u/ml

0.04

121

229

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

119

7.37

59.91

1.1

3.20

1.71

u/ml

0.51

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1096

6675

1.75

57.28

2.0

1.8

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

160

6.18

57.18

1.2

4.86

5.70

u/ml

0.16

132

(3021589) Normoblasts [#/volume] in Blood

3708

29863

1.46

56.32

13.1

10.7

0.00

e9/l

0.05

3012

24244

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1125

6983

1.71

54.71

2.0

1.8

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

7.84

53.83

2.2

1.6

16.63

4.81

u/ml

0.78

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2844

21940

1.47

52.94

3.9

3.4

—

2.15

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

128

6.61

52.42

1.1

0.69

1.69

u/ml

0.47

(3023430) Cat dander IgE Ab [Units/volume] in Serum

379

1632

2.39

52.31

1.1

11.85

6.11

u/ml

3.76

272

785

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

116

6.95

52.29

1.0

0.43

0.03

u/ml

2.54

(3011841) English Walnut IgE Ab [Units/volume] in Serum

155

5.98

52.02

1.2

8.33

7.20

u/ml

0.11

126

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

130

6.51

51.65

1.1

1.13

3.94

u/ml

0.40

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2310

17187

1.49

51.25

2.7

2.4

2.61

2.68

mg/l

0.82

2069

14966

(3020874) Milk IgE Ab [Units/volume] in Serum

219

722

3.09

51.02

1.5

1.1

10.79

1.41

u/ml

1.75

154

298

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1444

9759

1.59

49.71

4.8

4.3

0.80

0.82

mmol/l

6.35

1375

9249

(40758558) Short blood count panel - Blood

2551

19456

1.46

49.50

7.3

6.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

212

708

3.05

48.31

1.5

1.1

14.71

2.72

u/ml

1.12

151

238

(3042936) Bacteria identified in Isolate by Culture

1282

8502

1.61

47.56

2.2

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

339

1464

2.37

46.45

1.1

1.86

0.31

u/ml

2.63

203

497

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

114

6.53

45.72

1.1

0.56

0.40

u/ml

0.18

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3804

31506

1.41

45.54

7.5

6.3

11.64

11.71

umol/l

0.07

3609

29905

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5345

47039

1.44

45.00

4.8

4.2

11.46

10.24

mm/h

8.95

5086

44410

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1403

9615

1.56

44.93

2.1

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

2292

17421

1.45

44.09

3.6

3.2

0.41

0.34

e6/l

0.72

1703

12541

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

723

4200

1.79

43.82

1.8

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4923

42776

1.42

43.80

5.5

4.4

4815.03

1432.09

e6/l

1.16

546

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3238

26254

1.40

42.97

7.4

7.2

1.21

mmol/l

4.53

3066

24461

(3021960) Folate [Moles/volume] in Serum or Plasma

2123

16058

1.44

41.38

1.8

1.6

20.35

19.97

nmol/l

0.56

1895

14012

(3000494) Fungus identified in Specimen by Culture

1155

7714

1.58

41.03

1.6

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

743

4440

1.74

40.72

1.6

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

2554

20086

1.40

39.59

3.7

3.3

54.55

80.26

e6/l

0.75

1956

15072

(3000850) Epithelial cells [#/volume] in Urine

1840

13656

1.45

39.33

3.0

2.7

7.08

6.62

e6/l

0.33

1657

12385

(3015076) Soybean IgE Ab [Units/volume] in Serum

184

645

2.89

38.51

1.2

1.1

1.63

1.27

u/ml

0.15

138

202

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2392

18691

1.40

38.17

1.4

2.13

1.80

u/ml

0.44

661

5177

(3022948) Iron [Moles/volume] in Serum or Plasma

1476

10549

1.49

38.08

2.7

2.6

13.08

13.78

umol/l

2.71

1376

9902

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3530

29427

1.37

37.76

7.7

7.5

1.21

mmol/l

5.21

3080

25700

(3015736) pH of Urine

3426

28431

1.37

37.69

3.8

3.3

6.28

6.23

1.61

1819

16070

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5260

46727

1.39

37.66

9.8

7.8

82.09

78.70

u/l

3.83

5051

44479

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3108

25410

1.37

37.51

2.3

2.0

93.00

97.15

pmol/l

5.94

1777

13868

(3015377) Calcium [Moles/volume] in Serum or Plasma

2557

20263

1.39

37.34

3.8

3.3

2.35

mmol/l

1.86

2362

18668

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

7.88

37.34

1.0

31.58

16.68

u/ml

0.89

(3018095) Leukocytes [#/volume] in Urine

2965

24098

1.37

36.96

4.5

3.9

79.39

81.29

e6/l

0.05

2064

16241

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4188

35949

1.36

36.66

3.7

3.3

95.83

93.37

ug/l

0.22

3978

34100

(40768443) Skin Pathology biopsy report

492

2680

1.89

36.51

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1368

9711

1.49

36.29

2.6

2.42

2.40

g/l

0.81

1260

9026

(3026008) Bacteria identified in Urine by Culture

2361

18556

1.39

35.89

3.4

2.9

—

(3019977) pH of Arterial blood

927

6113

1.58

34.34

7.7

8.6

7.42

0.08

509

3308

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1257

8860

1.50

34.33

2.7

21.78

23.16

2.82

1167

8283

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

114

5.64

34.23

1.1

0.32

1.12

u/ml

0.54

114

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

925

6106

1.58

34.10

7.5

8.5

5.16

5.08

kpa

1.61

895

5871

(3027801) Oxygen [Partial pressure] in Arterial blood

925

6106

1.58

34.10

7.4

8.5

12.26

12.96

kpa

3.33

894

5869

(3035350) Ketones [Presence] in Urine by Test strip

4104

35393

1.34

33.35

4.4

3.7

9.49

4.28

estimate

0.72

860

7419

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

6.46

33.10

1.1

1.0

6.11

0.25

u/ml

1.42

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2745

22328

1.35

32.92

3.9

3.4

32.73

32.90

u/l

0.05

2603

21222

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1472

10781

1.45

32.91

3.8

2.7

2.44

2.43

mmol/l

0.95

1290

9646

(3003396) Base excess in Arterial blood by calculation

913

6069

1.57

32.57

7.5

8.5

1.21

0.75

mmol/l

2.58

744

4909

(40760892) CBC W Ordered Manual Differential panel - Blood

2070

16131

1.38

32.43

5.2

4.5

—

(3016502) Oxygen saturation in Arterial blood

830

5411

1.60

32.16

7.7

9.0

95.14

95.87

1.92

800

5217

(3021601) Nitrite [Presence] in Urine by Test strip

4054

35035

1.33

31.77

4.4

3.7

0.00

estimate

3.04

854

7341

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6137

56506

1.42

31.74

23.0

16.8

13.58

13.41

20.13

6070

55771

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

162

594

2.76

31.24

1.4

1.3

9.03

2.89

u/ml

3.51

126

330

(3009261) Glucose [Presence] in Urine by Test strip

4103

35584

1.32

31.04

4.5

3.7

0.00

0.06

estimate

0.70

831

7106

(3002173) Hemoglobin [Mass/volume] in Arterial blood

780

5069

1.60

30.56

8.1

9.3

121.39

122.32

g/l

0.59

761

4949

(3037467) Urinalysis macro (dipstick) panel - Urine

5006

44732

1.34

30.43

5.3

4.4

3.08

13.68

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

864

5760

1.56

30.31

2.7

2.6

0.21

0.22

g/l

0.23

807

5408

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3481

29581

1.32

30.03

2.8

2.5

74.59

74.32

nmol/l

0.24

3268

27508

(3014576) Chloride [Moles/volume] in Serum or Plasma

1076

7534

1.50

30.01

8.0

7.9

104.20

104.61

mmol/l

1.88

1076

7529

(3044889) 12 lead EKG panel

4622

40918

1.32

29.44

4.1

3.5

0.45

6867.63

0.68

(3007164) IgA [Mass/volume] in Serum or Plasma

2067

16337

1.36

29.01

1.5

2.34

2.18

g/l

3.99

1296

10430

(3026782) Osmolality of Urine

1555

11739

1.40

28.89

3.0

2.9

523.30

539.17

mosm/kgh2o

1.90

1355

10296

(3032080) INR in Blood by Coagulation assay

2979

24902

1.32

28.36

14.2

12.2

1.20

inr

0.13

2494

20738

(3019309) Folate [Moles/volume] in Red Blood Cells

1204

8713

1.45

28.23

1.9

1.7

1240.98

1161.73

nmol/l

2.20

942

6721

(3033658) Prothrombin time (PT) actual/Normal

2011

15886

1.36

28.16

4.8

4.5

91.86

91.68

0.12

1961

15526

(3011397) Hemoglobin [Presence] in Urine by Test strip

2032

16079

1.36

28.14

4.2

3.6

0.00

0.17

—

134

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2152

17202

1.35

27.81

2.5

2.2

197.90

215.54

u/l

0.43

2051

16395

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2392

19425

1.33

27.76

3.3

2.7

55.82

62.60

u/l

0.84

2242

18105

(3013826) Glucose [Moles/volume] in Serum or Plasma

4152

36420

1.30

27.23

6.0

5.1

6.45

6.46

mmol/l

0.10

3898

33872

(3008152) Bicarbonate [Moles/volume] in Arterial blood

520

3145

1.70

26.97

7.6

6.7

24.74

24.28

mmol/l

1.69

500

3001

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1121

8067

1.45

26.97

6.2

7.1

1.07

1.08

mmol/l

0.67

1064

7546

(3026493) Urate [Moles/volume] in Serum or Plasma

1906

15034

1.35

26.69

2.9

2.6

335.80

328.43

umol/l

2.45

1696

13575

(3036312) Salmon IgE Ab [Units/volume] in Serum

6.22

26.06

1.2

1.1

5.18

1.29

u/ml

1.27

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5681

52188

1.33

25.63

5.0

4.4

14.49

14.54

pmol/l

0.91

5332

48581

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1434

10871

1.39

25.61

3.1

2.9

1.02

1.08

e6/l

0.19

769

5601

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

173

4.07

25.43

1.6

9.34

8.71

ug/l

0.54

173

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

128

465

2.78

25.20

2.5

1.9

2.55

3.47

u/ml

0.37

145

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

882

6136

1.49

25.10

3.0

2.5

36.61

45.55

u/l

0.53

755

5192

(3016031) Almond IgE Ab [Units/volume] in Serum

102

5.12

25.10

1.1

1.60

1.37

u/ml

0.12

(3037522) Nuclear Ab [Titer] in Serum

1332

10023

1.40

24.77

1.4

438.21

538.24

titre

1.31

223

2050

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6829

64761

1.48

24.55

19.5

13.8

23.21

22.22

mg/l

1.71

5735

52307

(3019150) Specific gravity of Urine by Refractometry

1977

15906

1.32

23.69

4.5

3.7

1.02

1.31

kg/l

1.08

1271

10351

(3009508) Creatinine [Moles/volume] in Urine

2403

19863

1.30

23.65

3.6

3.5

7.68

7.93

mmol/l

1.60

2094

17316

(3027945) Reticulocytes/Erythrocytes in Blood

918

6511

1.46

23.62

2.7

3.2

1.72

1.73

0.08

831

5860

(3019420) Tryptase [Mass/volume] in Serum or Plasma

124

462

2.71

23.29

1.4

1.5

6.04

7.06

ug/l

0.75

108

420

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.97

22.89

1.0

1.1

0.02

0.04

u/ml

0.29

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

102

347

2.96

22.69

1.7

1.4

27.06

21.77

u/ml

0.27

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

4.96

22.42

1.1

16.40

8.28

u/ml

0.88

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1029

7541

1.42

22.09

2.9

3.2

7.38

umol/l

0.00

872

6517

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1260

9576

1.38

21.78

2.1

1.8

1.51

1.40

5.66

1109

8574

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

790

5540

1.47

21.45

4.1

3.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6387

60168

1.36

21.09

6.0

5.3

1.80

1.83

mu/l

1.19

6071

56829

(3036481) Cortisol [Moles/volume] in Serum or Plasma

937

6824

1.42

20.75

2.8

2.3

350.08

377.16

nmol/l

4.02

879

6341

(3000991) Gas panel - Venous blood

785

5563

1.46

20.14

8.9

10.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1356

10588

1.34

19.45

2.8

2.7

134.42

117.09

ug/g

0.84

1122

8467

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

194

954

2.06

19.41

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

746

5286

1.45

19.11

8.0

8.9

1.35

1.33

mmol/l

0.17

732

5185

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1500

11914

1.32

19.06

1.8

1.7

64919481.10

30994066.56

pmol/l

0.97

1297

10215

(3029937) Albumin [Presence] in Urine by Test strip

2245

18879

1.26

18.14

4.9

3.8

0.01

0.00

estimate

0.33

822

6904

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1358

10720

1.32

17.90

4.2

3.6

503.20

539.10

ng/l

0.06

960

7227

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

473

3091

1.56

17.88

9.3

11.2

16.06

16.13

0.23

455

2974

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1789

14665

1.28

17.75

1.9

2.0

1.16

1.10

mg/l

0.23

1364

11066

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1161

8979

1.34

17.60

2.3

2.7

29.50

29.60

0.25

1126

8749

(44816559) Phosphatidylethanol [Mass/volume] in Blood

497

3302

1.54

17.44

1.9

1.7

0.36

0.28

mg/l

1.90

248

1479

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3051

26682

1.23

17.10

4.4

3.5

0.01

0.22

estimate

1.13

734

6123

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1567

12692

1.29

16.97

1.4

1.3

27.93

25.86

iu/ml

0.23

420

3678

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1707

13996

1.28

16.76

3.2

3.3

1194.13

1233.43

ng/l

0.16

1452

11764

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

554

3805

1.49

16.60

3.0

3.3

172.19

179.46

ng/l

0.16

494

3414

(3017181) Myelocytes/Leukocytes in Blood

761

5551

1.41

16.54

4.6

4.7

0.90

0.82

0.27

198

1582

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1275

10080

1.32

16.49

3.2

3.0

3.56

3.07

e6/l

0.50

612

4777

(3023183) Ammonium ion [Moles/volume] in Plasma

243

1364

1.80

16.43

2.4

3.0

32.94

35.12

umol/l

0.71

227

1257

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

343

2.64

16.30

1.0

17.89

12.97

u/ml

1.00

230

(3012516) Albumin [Mass/volume] in Urine

1945

16280

1.26

15.95

3.7

3.5

66.47

53.47

mg/l

0.54

1259

10594

(36660697) Celiac disease serology panel - Serum

882

6635

1.37

15.90

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

449

6581

0.66

15.81

4.4

4.2

32.59

32.25

0.27

328

4682

(3002179) Metamyelocytes/Leukocytes in Blood

726

5297

1.41

15.73

4.4

4.5

0.60

0.64

0.19

181

1504

(3021440) Promyelocytes/Leukocytes in Blood

729

5332

1.40

15.57

4.7

4.8

0.12

0.11

0.03

167

1365

(3020682) Albumin/Creatinine [Ratio] in Urine

1966

16514

1.25

15.57

4.3

4.2

10.65

10.23

mg/mmol

0.09

1226

10585

(46235355) HIV 1 and 2 tests - Meaningful Use set

2364

20295

1.24

15.30

2.3

2.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

276

1649

1.70

15.02

1.6

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

720

5295

1.39

14.87

7.7

8.9

8.60

8.57

mmol/l

0.03

694

5106

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

591

4204

1.44

14.75

6.1

5.8

24.28

23.97

mmol/l

1.66

578

4172

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1437

11703

1.28

14.64

1.3

4.20

9.03

u/ml

6.25

535

4801

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

108

3.90

14.59

1.2

1.1

27.78

0.34

u/ml

0.53

(3025159) Blasts/Leukocytes in Blood

734

5433

1.39

14.58

4.8

5.0

0.57

0.15

0.38

157

1300

(3023103) Potassium [Moles/volume] in Serum or Plasma

6596

63106

1.31

14.51

21.2

15.3

3.93

3.94

mmol/l

3.78

6470

61622

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

283

1720

1.67

14.45

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

834

6314

1.36

14.38

5.5

5.3

5.89

5.81

kpa

1.50

807

6148

(3019550) Sodium [Moles/volume] in Serum or Plasma

6583

62981

1.31

14.36

21.1

15.2

139.36

139.62

mmol/l

15.78

6460

61657

(3026389) Candida sp identified in Specimen by Organism specific culture

192

1046

1.85

14.35

1.5

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

853

6506

1.35

14.00

4.0

4.7

241.96

242.42

u/l

0.02

820

6195

(3023520) Reticulocytes [#/volume] in Blood

659

4825

1.40

13.96

2.4

3.0

70.91

69.88

e9/l

0.26

443

3434

(3012544) pH of Venous blood

839

6388

1.35

13.93

5.5

5.3

7.37

0.95

465

3765

(3017143) Hepatitis C virus Ab [Presence] in Serum

1315

10652

1.28

13.91

1.8

1.7

—

(3002032) Base excess in Venous blood by calculation

812

6175

1.35

13.57

5.5

5.3

1.62

1.60

mmol/l

0.03

705

5283

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

553

3946

1.43

13.56

2.4

5.66

7.10

ug/l

1.77

493

3453

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

647

4748

1.39

13.51

9.0

11.1

24.76

24.64

mmol/l

0.37

642

4726

(3028707) Methadone [Presence] in Urine by Screen method

344

2231

1.56

13.48

2.8

2.9

—

(3018001) Oat IgE Ab [Units/volume] in Serum

4.63

13.46

1.1

1.0

3.77

0.11

u/ml

0.83

(3021879) Hepatitis B virus core Ab [Presence] in Serum

905

7007

1.33

13.39

1.6

1.5

—

(3012501) Base excess in Blood by calculation

209

1197

1.76

13.27

3.9

4.3

2.42

2.36

mmol/l

0.12

153

756

(3014765) Yersinia sp identified in Stool by Organism specific culture

296

1863

1.61

13.18

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

297

1874

1.61

13.09

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1680

1.64

13.08

1.9

2.3

10.93

10.34

g/l

1.37

242

1524

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2158

18589

1.22

13.07

1.9

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

294

1854

1.61

13.00

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1402

1.69

12.91

1.7

2.2

0.00

g/l

0.50

202

1244

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

219

1284

1.72

12.82

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

219

1284

1.72

12.82

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1946

16631

1.23

12.66

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

264

1632

1.64

12.66

1.9

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

460

3219

1.45

12.53

9.0

11.1

24.36

24.17

mmol/l

0.66

451

3161

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5953

56490

1.23

12.53

6.2

5.3

38.16

37.94

mmol/mol

1.15

5691

53647

(3020961) Endomysium IgA Ab [Titer] in Serum

576

4201

1.40

12.47

1.2

182.37

199.21

titre

0.08

133

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2373

20715

1.21

12.40

3.9

3.3

30.45

87.91

ng/l

1.36

1397

12019

(3047181) Lactate [Moles/volume] in Blood

264

1641

1.63

12.39

4.8

5.7

1.36

1.28

mmol/l

0.61

231

1437

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4971

46378

1.20

12.35

3.9

3.3

44.63

40.09

u/l

4.42

4728

44272

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

450

3156

1.45

12.12

1.7

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

266

1666

1.62

12.12

5.2

3.8

1.38

1.39

mmol/l

0.06

258

1636

(3014051) Protein [Presence] in Urine by Test strip

2288

19956

1.21

11.97

3.0

2.8

0.13

0.06

0.33

343

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

239

1465

1.65

11.87

1.7

2.2

0.01

0.02

g/l

0.92

213

1330

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

1482

1.64

11.83

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

219

1315

1.68

11.78

1.8

2.3

0.00

g/l

-0.00

202

1242

(3020630) Protein [Mass/volume] in Serum or Plasma

577

4260

1.38

11.61

2.1

2.7

66.95

66.69

g/l

0.38

525

3954

(3023419) Bacteria identified in Sputum by Culture

125

636

1.98

11.56

2.9

3.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

335

2242

1.51

11.42

1.6

1.9

0.24

0.23

g/l

1.69

319

2151

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

190

1110

1.73

11.32

1.7

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

719

5514

1.33

11.31

2.8

2.9

10.64

10.36

g/l

1.10

676

5124

(40768797) Stomach Pathology biopsy report

1023

8233

1.28

11.23

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

286

2.46

11.12

1.1

1.3

0.31

0.29

g/l

0.99

233

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6034

57565

1.22

10.84

24.6

17.2

332.65

332.97

g/l

1.89

6006

57220

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

340

2308

1.49

10.84

1.6

1.9

1.24

1.18

g/l

3.24

325

2219

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

1860

1.54

10.72

1.8

2.3

2.98

2.90

g/l

0.66

256

1715

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

1164

1.68

10.51

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

396

2788

1.44

10.48

1.3

0.28

1.18

u/ml

2.98

198

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

584

4391

1.35

10.48

4.2

4.5

76.33

80.85

ng/l

0.60

528

3893

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3379

30746

1.17

10.44

3.0

2.8

—

estimate

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

150

839

1.80

10.42

1.6

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

1962

1.52

10.39

1.8

2.3

3.96

3.69

g/l

2.41

267

1818

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

1964

1.52

10.34

1.8

2.3

4.35

4.23

g/l

1.58

266

1820

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

142

3.03

10.28

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

155

880

1.77

10.24

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

600

4546

1.34

10.23

3.1

2.6

70.13

72.55

ml/min/173m2

0.76

239

1867

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1965

1.51

10.12

1.8

2.3

7.45

7.32

g/l

0.64

266

1819

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

262

1708

1.55

10.12

1.9

2.3

0.51

0.86

g/l

1.35

221

1488

(3039000) Anion gap in Blood by calculation

180

1070

1.70

10.11

5.3

7.1

11.33

11.41

mmol/l

0.12

163

951

(3035933) Granulocytes/Leukocytes in Blood

250

1613

1.57

10.11

3.2

3.3

57.10

57.25

0.07

250

1613

(3018572) Chloride [Moles/volume] in Blood

180

1071

1.69

10.08

5.3

7.1

104.17

105.31

mmol/l

2.54

163

952

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

350

2.24

10.07

2.7

3.1

110.80

172.81

umol/l

1.61

192

(3021387) Prolactin [Units/volume] in Serum or Plasma

547

4100

1.36

10.02

1.7

322.31

311.55

mu/l

0.25

472

3700

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.60

9.96

1.7

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

509

3777

1.37

9.94

3.0

2.9

—

(40761536) Microorganisms panel - Urine sediment

706

5510

1.31

9.78

4.8

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

576

4369

1.34

9.75

3.8

3.9

1.22

1.23

mmol/l

2.18

489

3779

(1001926) Buprenorphine [Presence] in Urine by Screen method

556

4208

1.34

9.56

2.4

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

207

1297

1.61

9.50

1.7

14185.41

12593.17

e6/l

0.21

141

913

(3006653) Thiamine [Moles/volume] in Blood

315

2.26

9.44

1.4

1.3

135.56

132.47

nmol/l

0.20

315

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

460

3390

1.38

9.38

1.8

1.7

—

(3022145) Colonoscopy Study observation

854

6870

1.27

9.34

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

567

4319

1.34

9.33

1.8

1.9

1.26

1.29

g/l

0.17

543

4022

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5316

50366

1.17

9.28

3.9

3.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

268

2.36

9.23

1.2

1.3

111.12

107.95

0.47

241

(3052851) Hemolysis interference index of Serum or Plasma

255

1693

1.52

9.10

2.9

3.0

2.90

2.36

index

0.15

134

898

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2786

25156

1.17

9.08

2.0

1.8

1.42

1.36

mmol/l

3.03

2433

21940

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6922

67271

1.28

9.06

14.1

10.8

27.42

26.17

u/l

2.71

6773

65687

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

421

2.05

8.95

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

292

2001

1.47

8.94

2.1

2.0

2.40

2.09

ug/l

0.13

258

1787

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

179

1100

1.64

8.91

1.7

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

135

769

1.77

8.88

5.4

7.2

11.95

11.33

mg/l

0.66

127

721

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

195

1225

1.60

8.88

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

686

5409

1.29

8.80

5.2

5.0

4.71

4.74

kpa

0.17

659

5264

(3003181) Sodium [Moles/volume] in Urine

161

966

1.68

8.80

1.4

1.8

59.60

64.70

mmol/l

0.71

129

781

(44813793) Dust mix specific IgE antibody measurement

110

593

1.86

8.67

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

253

1695

1.51

8.67

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

530

1.91

8.65

1.9

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6937

67495

1.27

8.55

23.0

16.4

72.38

72.79

umol/l

0.53

6869

66715

(3019225) pH of Specimen

378

5120

0.72

8.49

4.3

3.9

7.34

7.35

0.21

293

3686

(3016879) Cocaine [Presence] in Urine

629

4949

1.29

8.20

2.3

2.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

146

874

1.68

8.08

1.6

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

229

1527

1.51

8.05

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

211

1383

1.54

8.04

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

418

1.99

8.04

1.8

1.6

494780.00

1568533.26

iu/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

332

2.11

7.96

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

284

1987

1.44

7.85

2.1

2.4

324.52

480.04

ug/l

1.12

265

1847

(3009445) Proteinase 3 Ab [Units/volume] in Serum

347

2518

1.39

7.82

1.3

1.6

4.70

13.44

iu/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

240

1632

1.48

7.69

2.5

2.6

—

(3025941) Bacteria identified in Stool by Culture

523

4053

1.31

7.65

1.3

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

154

952

1.63

7.56

1.5

1.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

154

952

1.63

7.56

1.5

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

154

952

1.63

7.56

1.5

1.7

—

(44790049) Parainfluenza type 3 nucleic acid detection

154

952

1.63

7.56

1.5

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

373

2756

1.37

7.54

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

283

1997

1.43

7.49

1.3

1.4

77.06

128.58

titre

0.99

197

(3008295) Osmolality of Serum or Plasma

121

706

1.72

7.40

1.5

1.6

277.96

282.23

mosm/kgh2o

1.24

546

(3009466) Valproate [Moles/volume] in Serum or Plasma

161

1016

1.59

7.28

5.7

5.8

350.07

374.06

umol/l

1.35

142

901

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

318

2305

1.39

7.24

4.8

5.1

1.81

1.65

1.25

299

2164

(3000764) Benzodiazepines [Presence] in Urine

662

5331

1.26

7.17

2.3

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

758

9159

0.81

7.10

1.8

3.39

3.45

ratio

0.58

543

6698

(3007461) Platelets [#/volume] in Blood

7265

71281

1.33

7.10

28.8

21.0

264.87

258.53

e9/l

13.53

7144

69950

(3000570) Elastase.pancreatic [Mass/mass] in Stool

256

1794

1.44

7.06

1.5

1.4

286.70

295.85

ug/g

0.26

152

978

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7266

71298

1.33

7.04

28.7

20.9

90.22

90.13

1.01

7215

70705

(3017732) Neutrophils [#/volume] in Blood

984

8286

1.21

7.02

2.9

3.0

5.30

4.41

e9/l

1.19

895

7323

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

339

2497

1.37

7.01

1.6

1.9

1.53

1.44

g/l

1.04

303

2157

(3035941) MCH [Entitic mass]

7266

71302

1.33

7.01

28.6

20.9

30.07

30.08

0.18

7215

70709

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.02

7.00

1.1

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

193

1281

1.52

6.99

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

735

6008

1.24

6.98

1.2

117.90

143.50

u/ml

1.11

267

2248

(3041096) Erythrocytes [Presence] in Urine by Automated

2204

19859

1.15

6.94

3.6

3.0

0.02

0.09

estimate

0.92

735

5949

(3000963) Hemoglobin [Mass/volume] in Blood

7267

71327

1.32

6.88

29.0

21.1

134.32

135.40

g/l

9.47

7215

70746

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7265

71306

1.32

6.86

29.3

21.4

40.28

41.07

3.78

7216

70674

(3006184) Hemoglobin [Mass/volume] in Capillary blood

207

1400

1.49

6.86

2.3

131.94

131.04

g/l

0.21

172

1142

(3010813) Leukocytes [#/volume] in Blood

7267

71330

1.32

6.85

28.8

21.0

7.10

6.75

e9/l

3.44

7134

69826

(3026361) Erythrocytes [#/volume] in Blood

7265

71310

1.32

6.83

28.7

20.9

4.50

4.53

e12/l

5.96

7124

69834

(3028300) Cannabinoids [Presence] in Urine

663

5372

1.25

6.81

2.3

2.1

—

(3027944) Amphetamines [Presence] in Urine

655

5305

1.25

6.75

2.3

2.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.62

6.72

1.2

1.0

59.54

0.10

u/ml

0.49

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

235

1637

1.45

6.71

2.9

5.2

0.35

0.34

iu/ml

0.21

132

899

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

215

1473

1.47

6.69

5.3

6.8

184.13

641.41

iu/ml

2.36

196

(3023323) Follitropin [Units/volume] in Serum or Plasma

649

5259

1.25

6.67

1.5

1.4

22.25

22.74

iu/l

0.16

544

4382

(3011985) Renin [Units/volume] in Plasma

141

884

1.60

6.59

1.3

1.6

50.08

72.58

mu/l

0.82

128

802

(3027008) Opiates [Presence] in Urine

659

5362

1.25

6.53

2.3

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

307

2253

1.38

6.52

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6047

58386

1.16

6.41

5.0

4.3

5.81

5.74

mmol/l

3.86

5707

54600

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1547

13666

1.16

6.29

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1122

9663

1.19

6.24

2.5

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

216

1504

1.45

6.21

2.3

3.5

35.59

58.18

mg/l

1.25

181

1282

(3034860) Kappa light chains.free [Mass/volume] in Serum

216

1505

1.45

6.19

2.3

3.4

61.06

88.30

mg/l

0.28

181

1281

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

329

2464

1.35

6.16

1.6

0.16

11.27

iu/ml

0.74

422

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

742

6164

1.22

6.06

9.0

5.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

143

921

1.56

6.00

1.2

—

(1616796) Gas panel - Central venous blood

192

1318

1.47

5.96

3.5

3.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

106

636

1.67

5.94

2.6

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

7.22

5.91

1.0

0.54

3.35

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

310

2317

1.35

5.90

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

945

8062

1.19

5.84

2.3

2.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

582

4731

1.25

5.83

3.1

3.5

4.47

4.58

pmol/l

2.24

521

4297

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

248

1792

1.39

5.82

4.6

3.6

166.45

2977.59

u/ml

1.11

216

1536

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

390

3023

1.30

5.76

1.5

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

193

1337

1.45

5.74

2.2

3.3

2.00

2.87

ratio

0.54

763

(3007930) Methemoglobin/Hemoglobin.total in Blood

286

2126

1.36

5.65

5.1

5.3

0.87

0.89

0.29

268

1999

(3020191) Ethanol [Moles/volume] in Serum or Plasma

102

616

1.66

5.60

1.6

1.5

1.46

1.24

promille

0.71

482

(3013139) Helicobacter pylori Ag [Presence] in Stool

563

4584

1.24

5.57

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

129

827

1.57

5.56

1.2

1.4

362.18

357.56

pmol/l

0.04

115

715

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

106

650

1.64

5.49

1.9

2.2

32.41

32.21

0.17

106

643

(3001964) Herpes simplex virus Ag [Presence] in Specimen

210

2.15

5.46

1.3

1.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

3.62

5.46

1.1

1.0

61.27

0.79

u/ml

0.48

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

318

2419

1.33

5.40

3.1

3.7

3.55

3.45

g/l

0.65

297

2311

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

313

1.92

5.39

1.6

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6081

58937

1.14

5.33

17.6

12.6

90.24

89.02

ml/min/173m2

4.13

5593

53376

(3052592) Norovirus Ag [Presence] in Stool

2.86

5.32

1.1

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

207

2.13

5.24

3.6

4.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

293

2215

1.33

5.21

1.2

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

282

2129

1.33

5.07

1.1

7.81

5.67

eliau/ml

0.21

292

(3009871) Measles virus Ab [Titer] in Serum

288

1.91

4.92

1.8

1.7

1376.00

3102.00

titre

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

331

1.85

4.90

1.6

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.86

4.89

1.0

1.1

0.12

0.02

u/ml

1.13

(3023420) DNA double strand Ab [Units/volume] in Serum

375

2975

1.27

4.69

1.9

2.0

8.53

6.56

iu/ml

0.38

719

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

591

7019

0.83

4.64

1.6

3.34

3.44

mmol/l

1.23

383

4607

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

479

1.67

4.61

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

479

1.67

4.61

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

479

1.67

4.61

1.7

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

557

1.62

4.57

1.1

1.3

182.00

182.69

titre

—

104

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

557

1.62

4.57

1.1

1.3

32.00

161.43

titre

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

115

756

1.53

4.51

2.1

2.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

166

1178

1.42

4.43

3.3

4.7

75836.29

1067.72

u/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

240

1812

1.33

4.37

2.3

2.7

5.94

6.83

umol/l

0.55

179

1352

(3002079) Sodium [Moles/time] in 24 hour Urine

301

1.83

4.34

1.4

152.96

164.14

mmol/24h

0.46

301

(1761868) Lipid panel - Serum or Plasma

2529

27030

0.90

4.32

2.8

2.7

—

(1175426) CD3 cells/Lymphocytes in Blood

103

669

1.54

4.29

2.6

2.5

75.43

71.93

2.08

643

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

150

1052

1.43

4.28

1.5

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

482

1.64

4.27

1.7

1.6

31.76

35.48

0.36

291

(3027135) IgG subclass 1 [Mass/volume] in Serum

118

791

1.50

4.25

1.5

1.4

6.45

6.62

g/l

0.28

588

(3024139) IgG subclass 3 [Mass/volume] in Serum

118

791

1.50

4.25

1.5

1.4

0.36

0.39

g/l

0.76

587

(3028192) IgG subclass 2 [Mass/volume] in Serum

118

792

1.49

4.22

1.5

1.4

2.89

2.87

g/l

0.06

591

(3019832) Treponema pallidum Ab [Presence] in Serum

1476

13331

1.13

4.21

2.0

1.9

—

(4062490) Immunoglobulin typing, IgG

116

777

1.50

4.20

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

470

1.64

4.16

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

176

1278

1.38

4.13

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

339

2706

1.26

4.07

1.6

1.7

9.87

11.97

u/ml

0.40

722

(3025018) Bordetella pertussis Ab [Titer] in Serum

106

702

1.51

4.06

1.3

1.1

—

(3004451) EKG impression Narrative

265

1.85

4.04

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

560

1.58

4.03

1.2

115.50

113.31

pmol/l

0.16

560

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

295

2319

1.28

4.02

2.8

3.5

172.75

177.65

0.45

284

2222

(3011412) CD3 cells [#/volume] in Blood

116

785

1.48

4.01

2.9

2.7

1382.26

1327.46

e6/l

0.25

643

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

236

1803

1.32

3.99

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

332

1.75

3.98

1.8

1.12

1.35

nmol/l

0.93

246

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1500

13610

1.12

3.95

2.6

2.3

—

(3051611) Lipemic interference index of Serum or Plasma

571

1.56

3.94

2.9

3.4

15.27

14.69

index

0.12

372

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

126

873

1.45

3.88

2.8

3.2

22.01

20.94

nmol/l

0.39

119

840

(3042631) Mycobacterium sp identified in Specimen

591

1.54

3.83

2.3

2.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

352

1.71

3.79

1.6

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

499

1.59

3.76

1.1

1517.71

1478.91

miu/ml

0.11

499

(3024928) Oxygen saturation in Venous blood

204

1541

1.33

3.75

6.4

5.1

64.04

63.20

0.21

190

1502

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

244

1.85

3.71

2.0

1.9

148.83

112.69

ug/min

0.20

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1617

14786

1.12

3.70

2.7

2.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

297

1.75

3.63

1.1

1.3

116.57

105.92

1.11

273

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

110

2.27

3.59

1.4

—

(4198724) Urine methamphetamine measurement

530

1.55

3.56

2.5

3.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

263

1.79

3.52

1.1

—

(3002619) Bacteria identified in Specimen by Culture

178

1.97

3.50

1.3

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

106

726

1.46

3.50

1.2

1.1

6.15

7.25

iu/ml

0.21

186

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

216

1663

1.31

3.50

1.4

1.5

5.17

10.75

iu/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

385

3179

1.22

3.45

1.5

9.05

9.24

u/l

0.12

295

2488

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

386

1.63

3.42

2.5

2.6

43.21

42.72

0.07

207

(3037756) Immunofixation for Serum or Plasma

129

922

1.40

3.40

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

296

1.72

3.39

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

617

1.49

3.39

1.6

57.71

53.76

0.39

386

(3033705) Calcium.ionized [Moles/volume] in Venous blood

513

0.48

3.38

2.6

2.3

1.17

1.20

mmol/l

2.08

504

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

216

1672

1.30

3.38

1.3

46.81

40.56

u/ml

0.16

152

(3048929) Epstein Barr virus Ab [Presence] in Serum

429

3588

1.21

3.38

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

282

1.74

3.36

1.1

1.3

96.14

90.25

0.48

131

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

268

2134

1.26

3.35

1.3

22.83

37.76

u/ml

0.64

122

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

332

2711

1.23

3.32

2.2

2.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

345

1.65

3.26

1.1

1.2

93.48

102.37

u/l

0.22

293

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

568

4891

1.17

3.21

5.9

4.2

30.29

26.88

ug/l

0.10

463

3832

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

3.79

3.17

1.4

2.0

39.80

55.53

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

405

3394

1.20

3.14

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

288

1.70

3.14

1.1

92.23

92.14

0.01

130

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

104

2.21

3.13

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

229

1.79

3.13

2.5

2.6

67.31

84.87

ug/l

0.65

220

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

633

5512

1.16

3.11

2.8

2.4

6797.61

6724.86

u/l

0.02

240

2203

(3044640) Blood type and Crossmatch panel - Blood

2251

21091

1.09

3.09

2.6

2.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

494

4221

1.18

3.08

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

318

2608

1.23

3.08

4.2

4.3

50.66

48.81

0.67

313

2561

(3004119) Hemoglobin [Mass/volume] in Venous blood

414

3486

1.20

3.06

5.0

4.3

130.05

129.97

g/l

0.02

403

3394

(3020911) Cortisol [Moles/time] in 24 hour Urine

268

1.72

3.05

1.3

1.4

70.84

216.56

nmol/24h

0.77

268

(3040151) Glucose [Moles/volume] in Capillary blood

101

706

1.43

3.05

3.0

5.5

6.89

7.02

mmol/l

0.18

599

(40757494) Bilirubin.total [Moles/volume] in Blood

306

1.67

3.04

2.2

3.0

72.68

92.70

umol/l

0.36

(3024263) Appearance of Synovial fluid

263

1.71

2.96

1.5

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

205

1609

1.28

2.93

1.2

1.3

2.42

3.17

u/ml

0.26

106

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

411

1.56

2.92

1.6

—

(3000012) Reticulocyte production index

688

1.43

2.91

2.0

2.1

0.91

0.90

0.07

449

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

581

1.47

2.90

1.2

82.91

72.05

u/l

0.24

515

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

162

1234

1.32

2.90

1.8

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

334

1.62

2.88

1.1

1.2

25.04

25.48

u/l

0.02

279

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

244

1.72

2.84

2.4

2.3

17.04

16.03

umol/l

0.22

244

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

676

1.42

2.81

2.0

1.9

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

119

873

1.37

2.75

1.3

0.53

2.58

nmol/l

0.51

113

844

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

564

1.46

2.73

1.5

1.4

1.67

1.44

nmol/l

1.03

510

(3018333) Ribosomal P Ab [Presence] in Serum

581

1.45

2.72

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

339

0.44

2.71

1.4

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

508

1.48

2.70

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.71

2.70

1.3

1.0

—

(3036489) Thrombin time

336

2812

1.20

2.69

2.3

3.0

21.03

21.07

0.04

303

2467

(3030981) Hyaline casts [#/volume] in Urine by Automated count

537

4676

1.16

2.68

2.5

2.4

0.60

0.36

e6/l

0.88

496

4431

(3049717) Cytology report of Urine Cyto stain

203

1612

1.26

2.67

1.9

2.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

120

887

1.36

2.66

1.3

41.51

55.73

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

211

1687

1.26

2.63

1.4

1.6

150.81

136.04

au/ml

0.85

502

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

144

1097

1.32

2.61

2.5

2.4

106.05

104.02

ug/min

0.01

688

(3025130) Human papilloma virus identified in Specimen

182

1433

1.27

2.58

1.7

1.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

122

910

1.34

2.57

1.3

0.10

0.34

nmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

130

979

1.33

2.56

5.2

3.7

92.23

624.69

u/ml

1.28

120

901

(3010838) Calcium [Moles/time] in 24 hour Urine

136

1031

1.32

2.56

1.9

2.0

4.92

5.14

mmol/24h

0.39

126

933

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

338

1.57

2.54

1.6

5.35

5.69

u/l

0.08

277

(1761482) Bacteria [#/volume] in Urine by Culture

1162

0.71

2.52

3.2

3.9

—

(3016038) Potassium [Moles/volume] in Urine

411

1.51

2.50

1.2

1.7

30.02

35.12

mmol/l

1.17

379

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

600

1.42

2.50

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

262

1.64

2.48

1.5

2.30

4.22

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

601

1.42

2.48

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

453

1.48

2.47

1.6

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1715

16024

1.09

2.45

2.5

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

173

1364

1.27

2.45

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

628

1.40

2.44

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

195

1.74

2.44

1.5

1.4

196.07

129.51

nmol/l

0.31

145

(3042517) Benzodiazepines panel - Urine

137

1.90

2.43

1.5

2.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.13

2.43

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

256

1.64

2.43

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

613

1.41

2.41

2.8

548.42

536.80

e6/l

0.09

461

(3041354) Potassium [Moles/volume] in Venous blood

530

0.58

2.40

2.3

3.92

4.04

mmol/l

1.08

521

(3037121) Protein [Mass/volume] in Urine

264

2187

1.21

2.39

4.5

3.9

278.10

423.28

mg/l

1.08

159

1083

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

623

1.40

2.38

1.1

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

528

0.58

2.38

2.3

105.71

105.35

mmol/l

0.16

519

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

237

1944

1.22

2.37

1.3

1.4

243.92

239.23

u/ml

0.08

137

1180

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

302

2537

1.20

2.36

2.5

3.9

92.98

94.07

0.39

290

2453

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

624

1.40

2.36

1.1

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

642

1.39

2.34

1.1

1.2

—

(1002224) Polysomnography panel

405

3494

1.17

2.32

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

241

1987

1.22

2.30

1.3

7.70

5.18

u/ml

0.31

186

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

187

1504

1.25

2.26

1.4

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

208

1.68

2.24

1.7

—

(3008898) HLA-B27 [Presence]

363

3115

1.17

2.24

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

160

1266

1.27

2.23

1.5

1.6

0.78

0.73

g/l

0.24

128

1007

(3003740) Influenza virus B Ag [Presence] in Specimen

219

1796

1.22

2.22

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

219

1799

1.22

2.19

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

219

1799

1.22

2.19

1.4

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

367

3160

1.17

2.17

1.9

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

244

2032

1.21

2.13

3.3

3.8

25.22

24.47

mmol/l

2.44

239

1998

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

123

948

1.30

2.12

1.1

1.2

3.29

21.12

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

102

766

1.33

2.11

1.3

0.18

0.20

nmol/l

0.39

592

(3028626) Oxygen [Partial pressure] in Capillary blood

286

2419

1.19

2.11

6.4

7.3

8.84

9.01

kpa

0.86

277

2362

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

130

1.85

2.10

1.1

1.4

44.13

36.16

0.35

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

478

1.42

2.10

4.1

4.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

533

4727

1.13

2.10

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

116

1.90

2.09

1.3

1.9

6.24

381825.38

nmol/l

1.08

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.56

2.07

2.2

1.7

33.00

46.70

umol/l

1.52

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

238

1984

1.20

2.07

1.3

11.69

10.09

u/ml

0.10

285

(3014891) Appearance of Pleural fluid

0.00

2.06

0.0

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

168

1352

1.25

2.05

7.2

5.2

63.62

62.99

0.14

168

1347

(3010144) Erythrocytes [#/volume] in Synovial fluid

464

1.42

2.05

1.4

151729.22

92950.89

e6/l

0.21

317

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

710

1.34

2.04

1.1

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

117

1.88

2.04

3.2

3.0

18.71

24.93

mg/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

334

2873

1.17

2.03

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

391

1.46

2.01

2.5

2.8

0.26

0.32

e9/l

0.64

201

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

367

1.47

2.00

1.8

1.6

4.99

4.45

nmol/l

0.09

279

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

1.69

1.97

7.1

3.0

5.28

4.78

kpa

0.96

178

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

1.69

1.97

7.0

3.0

10.46

10.74

kpa

0.24

178

(3027456) Digoxin [Moles/volume] in Serum or Plasma

100

760

1.32

1.94

2.9

3.3

0.77

0.82

nmol/l

0.79

608

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

717

1.33

1.93

1.3

1.2

—

32.91

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

203

1681

1.21

1.91

1.8

2.1

10.75

11.15

mg/l

0.31

192

1584

(3035320) C reactive protein [Mass/volume] in Body fluid

539

1.37

1.90

2.9

2.4

28.53

26.81

mg/l

0.14

384

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

494

0.62

1.88

1.9

1.4

—

(3045414) Leukocytes [Presence] in Urine

661

5980

1.11

1.88

2.1

2.0

0.01

0.02

estimate

0.35

149

1373

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

243

2051

1.19

1.87

1.3

1.4

54.54

54.28

u/ml

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

559

1.36

1.84

13.5

12.7

0.59

mmol/l

0.03

515

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

347

3019

1.15

1.84

1.7

2.0

—

32.21

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

628

1.34

1.84

2.9

217.79

218.32

e6/l

0.01

490

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

213

1.60

1.83

1.6

1.9

0.13

0.21

nmol/l

1.03

156

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1109

10302

1.09

1.82

4.3

4.1

20.74

21.89

1.62

461

4588

(3017446) Testosterone [Moles/volume] in Serum or Plasma

586

5282

1.12

1.80

2.5

2.3

11.83

12.10

nmol/l

0.30

524

4814

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

287

1.50

1.77

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

287

1.50

1.77

1.9

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

287

1.50

1.77

1.9

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

287

1.50

1.77

1.9

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.16

1.76

1.3

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

109

1.83

1.76

1.5

1.2

0.82

183.51

mg/l

1.72

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

200

1.60

1.75

2.8

2.6

0.59

0.62

mmol/l

0.96

200

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

191

1589

1.21

1.75

1.9

185.03

196.99

pmol/l

0.84

174

1514

(3039443) Prostate specific Ag panel - Serum or Plasma

810

0.73

1.70

1.5

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

315

1.46

1.69

1.4

1.3

—

(40768441) Liver Pathology biopsy report

492

1.36

1.67

1.4

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

141

1.70

1.66

1.4

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

538

4851

1.12

1.66

2.4

14.95

18.53

au/ml

0.88

599

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

737

1.29

1.63

1.7

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.24

1.62

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

402

1.39

1.61

1.8

1.5

5.65

6.23

u/l

0.44

353

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

185

1550

1.20

1.60

1.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.00

1.57

1.2

1.0

331.67

250.20

u/ml

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

320

1.44

1.57

1.2

1.3

180.03

308.96

u/l

1.56

296

(3044007) Cell count panel - Peritoneal fluid

159

1.63

1.57

1.5

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

329

1.43

1.56

30.7

30.8

100.97

125.44

ug/l

1.87

277

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

314

2751

1.15

1.56

1.5

1.6

61.14

60.23

ug/l

0.10

314

2751

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

321

1.43

1.55

1.4

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

1.52

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.59

1.51

1.0

2.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6252

61624

1.07

1.51

5.5

4.8

2.67

2.76

mmol/l

14.78

5962

58466

(3023487) Leukocytes [#/volume] in Peritoneal fluid

178

1.57

1.47

1.4

2.2

854.58

766.11

e6/l

0.14

130

(3028433) Virus identified in Specimen by Culture

210

1.52

1.47

1.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

600

1.30

1.46

1.1

—

(44806071) Cardiolipin IgM antibody measurement

109

1.74

1.45

1.1

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.45

6.1

4.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

542

1.31

1.41

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

146

1213

1.21

1.41

1.1

3.07

3.42

eliau/ml

0.16

574

(3026692) Albumin [Mass/volume] in Peritoneal fluid

133

1.65

1.41

1.1

1.5

13.97

12.90

g/l

0.22

101

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

245

1.47

1.40

1.6

1.5

13.98

14.44

pmol/l

0.26

204

(3017569) Oxygen content in Arterial blood

270

1.44

1.40

2.0

2.4

16.23

16.33

0.07

270

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

773

1.26

1.39

1.5

8.14

7.78

mmol/l

0.39

754

(3042111) Morphology [Interpretation] in Bone marrow Narrative

104

836

1.25

1.39

1.6

1.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.89

1.38

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

536

1.31

1.37

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1372

12993

1.07

1.37

4.9

2.39

2.89

ug/l

0.41

1235

11771

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

119

1.68

1.36

1.8

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

271

2377

1.14

1.36

3.3

3.8

24.90

25.16

mmol/l

0.58

263

2285

(3016135) IgD [Mass/volume] in Serum

2.94

1.35

1.0

1.2

27.32

35.26

mg/l

—

(4034850) Laboratory test

210

1809

1.16

1.35

12.0

8.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

119

974

1.22

1.35

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

123

1011

1.22

1.34

1.2

1.1

0.35

1.12

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.75

1.34

1.1

0.84

0.68

umol/24h

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

496

4514

1.10

1.33

1.3

47.28

46.96

au/ml

0.01

269

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

315

1.40

1.33

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

120

1.67

1.33

1.4

1.2

337.00

265.33

pmol/l

0.51

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

646

1.27

1.31

1.8

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

256

2246

1.14

1.29

1.2

4.45

4.35

0.05

320

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

1218

1.19

1.28

1.2

1.1

3.08

2.79

0.11

209

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

118

972

1.22

1.28

1.1

1.55

1.47

g/l

1.23

113

889

(3020650) Glucose [Presence] in Urine

259

1.43

1.27

1.6

0.00

0.03

estimate

1.08

259

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

443

4022

1.11

1.26

5.8

6.0

1.73

1.37

mmol/l

1.24

318

2944

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.04

1.26

1.2

1.7

13.06

20.82

pmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

286

1.40

1.23

1.4

1.6

3.27

3.46

u/field

0.03

212

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

320

1.37

1.23

1.4

2.1

76.33

106.47

ng/l

3.17

320

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.00

1.23

1.2

1.6

248.61

519.53

nmol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

155

1.55

1.21

1.5

1.9

16217.46

17049.36

e6/l

0.02

(3009343) pH of Capillary blood

486

4448

1.10

1.19

5.7

5.9

7.41

0.41

403

3694

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

261

2311

1.13

1.17

6.8

7.9

1.41

1.32

mg/l

1.06

248

2180

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

302

2699

1.12

1.17

1.8

1.9

42.72

39.28

u/l

2.36

270

2474

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

343

3790

0.90

1.16

1.5

1.24

1.20

ratio

0.34

192

2281

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

343

3790

0.90

1.16

1.5

0.94

0.95

ratio

0.16

191

2267

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

316

1.36

1.15

11.0

6.5

208.71

10824.92

u/ml

0.49

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

342

3776

0.90

1.15

1.5

1.13

1.15

ratio

0.16

190

2253

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

335

3702

0.90

1.14

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.68

1.13

1.5

1.3

0.65

0.41

iu/ml

0.43

(3044009) aPTT.lupus sensitive (LA screen)

1.84

1.12

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

191

1.47

1.12

1.2

80.17

69.18

—

(3046861) Legionella sp Ag [Presence] in Urine

2.33

1.12

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

147

1254

1.17

1.12

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

111

1.62

1.11

1.0

1.1

269.17

370.81

u/ml

—

(3013466) aPTT in Blood by Coagulation assay

1.96

1.10

1.1

34.23

36.59

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

379

1.32

1.10

4.4

4.0

8.44

9.34

mg/l

0.50

306

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

142

1210

1.17

1.10

1.3

5.67

4.50

u/ml

0.43

574

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.26

1.10

1.0

1.1

0.16

0.04

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.78

1.10

13.3

11.7

5.37

5.84

mmol/l

0.30

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

881

1.20

1.09

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

412

3762

1.10

1.08

2.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.95

1.08

1.0

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

303

1.35

1.07

3.4

6.2

77.53

70.26

mg/l

0.39

238

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.12

1.05

1.0

0.13

0.05

u/ml

—

(3041806) Other cells [#/volume] in Blood by Manual count

605

1.24

1.04

1.8

1.5

0.53

0.50

e9/l

0.40

605

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.27

1.03

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.27

1.03

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

327

2961

1.11

1.03

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

588

1.24

1.02

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

642

0.78

1.01

3.0

2.1

12.40

21.65

mg/l

2.99

230

(3047007) Chlamydophila sp Ab [Presence] in Serum

146

1258

1.16

1.01

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

250

0.64

1.00

2.2

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

186

2107

0.88

1.00

2.2

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

717

1.21

0.99

1.2

1.1

23.15

15.94

u/ml

0.38

274

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.61

0.99

1.7

2.07

1.69

mg/l

0.12

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

308

1.33

0.98

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.80

0.97

1.5

1.6

192.67

135.49

ug/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

491

4546

1.08

0.97

5.7

5.8

5.21

5.10

kpa

2.24

470

4382

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6181

61110

1.05

0.96

4.9

4.4

4.55

4.66

mmol/l

17.04

5903

58231

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

100

1.60

0.96

2.5

2.8

9.25

321.06

ug/l

0.56

100

(3013512) EKG study

1728

17866

0.96

0.94

3.2

0.67

0.76

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.65

0.93

2.1

2.0

6.34

7.62

mmol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.65

0.93

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

191

1.41

0.93

1.2

69.60

82.44

—

(3001019) Free T4 and TSH panel - Serum or Plasma

397

4297

0.92

0.93

1.6

1.7

—

(21494755) Public health laboratory ask at order entry panel

765

8080

0.94

0.92

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

660

1.21

0.92

1.7

1.70

1350.56

pmol/l

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

102

1.57

0.89

2.5

2.6

176.50

166.52

ug/g

0.15

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.07

0.89

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

103

0.48

0.89

1.0

1.3

—

8.26

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

253

1.34

0.89

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

420

1.26

0.88

1.5

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

1.69

0.88

1.1

1.2

50.14

57.56

—

(40757373) Influenza virus identified in Isolate

103

1.55

0.86

1.7

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

620

1.21

0.86

2.7

3.3

8.76

13.85

nmol/l

0.23

599

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

203

1.38

0.86

1.6

—

213.60

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

307

1.30

0.86

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.82

0.85

1.0

1.5

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

1.82

0.85

1.4

75.24

75.18

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.62

0.84

1.2

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.56

0.83

1.7

1.99

1.83

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.56

0.83

1.7

1.16

1.45

mg/l

0.30

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.56

0.83

1.7

4.48

4.22

mg/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

1290

1.14

0.83

3.6

2.2

1.04

0.82

nmol/l

1.49

128

1110

(3048879) Bone marrow aspiration report

113

0.53

0.82

1.8

2.1

—

2.00

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

190

1696

1.12

0.82

1.5

1.7

3.59

3.61

mmol/l

0.17

177

1611

(3000093) Morphology [Interpretation] in Blood Narrative

569

1.21

0.82

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

154

1.43

0.82

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

679

1.19

0.82

1.1

—

(3020491) Glucose [Moles/volume] in Blood

497

1.23

0.82

1.6

1.7

6.38

6.23

mmol/l

0.19

374

(4133840) Spirometry

189

0.63

0.81

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

100

855

1.17

0.81

1.1

93.30

96.20

0.49

802

(3000330) Specific gravity of Urine by Test strip

263

2876

0.91

0.80

2.7

3.1

1.02

ratio

0.04

223

2542

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

114

1.49

0.78

1.5

1.3

1.97

1.44

iu/ml

0.55

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

710

1.18

0.78

1.3

5.12

5.80

umol/l

0.87

640

(3022670) pH of Venous cord blood

0.52

0.78

1.2

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.51

0.77

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.58

0.77

6.8

4.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

510

1.22

0.77

2.6

2.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

322

1.27

0.76

3.8

2.4

9.93

9.54

mg/l

0.18

277

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.76

0.0

1.0

—

(4268621) Lupus anticoagulant assay

103

890

1.16

0.74

2.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

341

1.26

0.74

2.8

3.0

133.83

139.76

au/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

166

1.38

0.74

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

179

1605

1.12

0.74

1.1

18.35

17.27

au/ml

0.06

396

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1087

0.86

0.73

2.3

2.6

22.64

27.87

iu/ml

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.00

0.72

2.6

2.0

267.20

298.36

ug/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.79

0.72

5.0

3.5

—

(3047189) Immunofixation for 24 hour Urine

218

0.69

0.72

1.5

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

228

1.31

0.71

1.9

3.8

1.55

1.16

0.54

228

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

273

1.28

0.70

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

376

4019

0.93

0.69

1.5

58.75

62.06

ug/l

0.66

310

3416

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

169

0.65

0.69

1.0

1.2

—

22.83

u/ml

—

(21494434) Karyotype in Bone marrow

472

1.21

0.69

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

204

0.68

1.4

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

1.85

0.68

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

135

1.41

0.68

1.2

37.91

39.05

g/l

—

(3007463) Buprenorphine [Presence] in Urine

1.52

0.68

3.6

4.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6134

60767

1.04

0.67

4.7

4.3

1.42

1.46

mmol/l

15.26

5840

57633

(4094501) Cardiovascular stress test using bicycle ergometer

162

1456

1.11

0.67

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

807

7709

1.05

0.66

2.9

3.0

0.65

0.75

ug/l

3.01

489

4665

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.53

0.66

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.51

0.65

3.5

2.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

128

1138

1.12

0.64

1.1

116.10

114.37

0.22

115

1039

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

525

0.82

0.64

1.2

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.72

0.63

1.2

1.0

—

(3045142) Bone marrow Pathology biopsy report

615

1.17

0.63

1.3

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

211

2297

0.91

0.63

2.3

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

718

1.16

0.62

3.9

4.8

82.81

90.10

u/ml

0.06

230

(3028717) Thiamine [Mass/volume] in Blood

104

1.44

0.62

1.1

1.3

71.27

64.79

ug/l

0.49

104

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

243

1.27

0.61

1.1

37.75

33.89

iu/ml

0.15

243

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

290

0.76

0.61

1.2

1.0

817.00

747.87

ng/l

0.35

200

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

462

1.19

0.59

1.1

1.30

1.09

u/l

0.27

183

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.54

0.59

1.0

—

3.40

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

207

1899

1.09

0.59

1.5

1.7

486.08

485.57

mg/l

0.00

199

1818

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.66

0.56

3.0

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

132

1.36

0.56

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5802

57482

1.03

0.56

4.1

3.8

1.31

1.25

mmol/l

9.85

5484

54203

(3034092) Cytoplasmic Ig cells/cells in Blood

0.56

0.55

10.4

6.5

0.28

0.19

—

(3044242) Glucose [Moles/volume] in Arterial blood

293

1.23

0.54

3.4

2.1

7.91

8.05

mmol/l

0.08

293

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

248

1.25

0.54

1.0

1.1

—

(4024509) Urine culture

304

2845

1.07

0.54

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

449

1.18

0.54

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

691

1.14

0.54

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

404

0.81

0.53

1.2

7.45

8.69

mm/h

0.56

404

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

294

3130

0.94

0.53

1.0

1.1

0.65

0.62

ratio

0.25

313

(3003694) ABO and Rh group [Type] in Blood

2270

22220

1.03

0.53

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

240

1.25

0.53

2.6

1.8

13.00

158.35

au/ml

—

(4195642) Thrombophilia screening test

125

1128

1.11

0.52

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.60

0.51

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

205

1.27

0.51

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

100

0.60

0.51

2.2

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

258

0.77

0.50

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.46

0.50

4.2

8.3

11.71

10.71

0.60

(3005570) Glucose [Moles/volume] in Urine

602

1.15

0.50

2.5

2.1

—

0.82

—

(3050129) First trimester maternal screen panel - Serum or Plasma

459

4809

0.95

0.50

1.4

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

153

1.31

0.49

1.5

1.6

—

0.91

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

182

1678

1.08

0.49

1.6

1.8

19.37

26.35

e6/l

0.33

145

1224

(3007916) DNA double strand Ab [Titer] in Serum

1.49

0.49

1.0

1.4

—

115.99

—

(3019174) dRVVT (LA screen)

1.49

0.49

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

172

1583

1.09

0.49

1.6

1.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.52

0.48

1.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.49

0.47

1.0

5.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

138

1260

1.10

0.47

1.3

2.95

3.73

u/ml

0.29

489

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

114

1032

1.10

0.46

1.2

1.3

353.33

421.40

titre

—

(4146454) Self-monitoring of blood glucose

493

0.85

0.46

2.5

2.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

182

1.26

0.45

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.62

0.45

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.45

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

223

2083

1.07

0.45

2.1

2.2

3.59

6.33

iu/l

0.54

929

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

183

1698

1.08

0.44

1.7

1.8

661.06

3231.56

e6/l

0.59

151

1313

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

779

1.12

0.44

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

391

3719

1.05

0.44

1.4

196.81

229.37

miu/ml

1.13

188

1799

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

143

1314

1.09

0.44

1.8

1.6

420.03

358.90

mu/l

0.42

114

1068

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

376

1.17

0.43

1.1

1.2

—

(3001556) Androgen free Index in Serum or Plasma

129

0.70

0.43

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

535

1.14

0.43

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

371

0.83

0.43

1.1

1.2

13.67

14.05

u/ml

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

414

1.16

0.42

1.1

0.12

5.48

nmol/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

260

0.81

0.40

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

1215

1.09

0.40

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.33

0.40

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.33

0.40

1.3

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

10694.40

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.40

0.0

3.6

—

139.33

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

204

1.22

0.40

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

1.23

0.40

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

315

1.17

0.39

2.7

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

315

1.17

0.39

2.7

2.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

399

0.85

0.39

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.4

—

2.07

—

(40768800) Prostate Pathology biopsy report

748

0.89

0.39

1.3

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

550

1.13

0.38

1.2

0.62

0.66

ratio

0.39

325

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

178

1.23

0.38

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

307

2918

1.05

0.37

1.5

1.7

5.58

4.25

mg/l

0.84

231

2102

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

206

1.21

0.37

1.4

1.2

—

(3042733) HLA Ab [Presence] in Serum

252

1.19

0.37

4.5

4.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

450

0.86

0.37

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

308

1.17

0.36

1.0

-2.74

-1.25

mmol/l

—

(3006598) pH of Arterial cord blood

308

1.17

0.36

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.46

0.36

1.3

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.36

0.36

7.0

5.9

32.00

47.08

ug/min

0.74

(3023410) Appearance of Cerebral spinal fluid

858

0.91

0.35

2.0

2.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

244

0.82

0.35

3.6

3.1

52.05

45.10

0.92

244

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

244

0.82

0.35

7.2

6.2

7.00

8.73

0.94

244

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

123

0.73

0.35

1.0

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

207

2185

0.94

0.34

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

478

0.88

0.34

1.2

1.4

12905.33

70750.82

e6/l

2.42

271

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.34

0.33

1.6

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

116

1248

0.93

0.33

4.4

3.2

26.10

25.59

mg/l

0.05

828

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.32

0.33

1.8

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

100

1.30

0.33

1.8

5.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

497

0.88

0.32

1.1

1.09

1.06

ratio

0.39

409

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

701

1.10

0.32

1.2

1.1

38.75

38.74

mg/l

0.00

590

(40758292) HTLV I+II Ab panel - Serum

154

0.78

0.32

1.2

1.3

—

(3034426) Prothrombin time (PT)

238

1.18

0.32

1.1

1.3

28.00

28.64

0.22

238

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

271

2831

0.95

0.31

7.4

6.7

24.38

24.41

mmol/l

0.07

253

2703

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

128

1.25

0.31

1.6

2.0

—

10560.00

—

(3017509) Phencyclidine [Presence] in Urine

119

1.26

0.31

1.6

—

(3045424) Erythrocytes [Presence] in Urine

321

3075

1.04

0.31

2.1

2.0

0.01

0.25

estimate

0.54

125

1075

(3026726) Creatinine [Moles/volume] in Specimen

1.34

0.31

1.6

2.3

861.57

536.19

umol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

1.21

0.30

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1066

0.93

0.30

1.6

1.4

6.72

6.87

mmol/l

0.25

974

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

195

0.82

0.29

1.3

1.6

39.08

40.76

g/l

0.54

195

(3029634) Reagin Ab [Titer] in Serum by VDRL

139

1305

1.06

0.29

2.6

1.9

12.83

17.79

titre

—

(3004809) Band form neutrophils/Leukocytes in Blood

918

1.08

0.29

3.5

1.22

1.43

0.35

824

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.23

0.29

6.9

8.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

296

3075

0.96

0.28

1.5

—

(40768806) Pleura Pathology biopsy report

449

0.89

0.28

1.3

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.31

0.27

4.5

6.5

—

(3005033) Fetal Nuchal fold Thickness US

288

2990

0.96

0.27

1.5

1.27

1.26

0.22

216

2206

(3000919) Neutrophils/Leukocytes in Pleural fluid

119

0.75

0.27

1.3

1.5

46.90

24.04

—

110

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

680

1.09

0.27

1.1

222.70

235.81

mg/l

0.30

603

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

140

1.21

0.27

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

556

1.10

0.26

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

652

1.09

0.26

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

182

0.82

0.26

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

633

1.09

0.26

1.2

78.40

45.62

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

122

1.23

0.26

1.1

1.4

1.17

mmol/l

0.03

122

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

662

1.09

0.26

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

467

0.90

0.26

1.3

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

206

1.16

0.25

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

206

1.16

0.25

2.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

206

1.16

0.25

2.5

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.25

0.25

1.3

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

303

3134

0.96

0.25

1.6

—

(3002256) Pathology report gross observation

828

8100

1.02

0.24

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

105

1.24

0.24

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.26

0.24

1.4

1.7

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.26

0.24

1.3

1.4

29.73

23.43

0.28

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

165

1570

1.05

0.23

1.4

1.5

71.01

128.85

pmol/l

3.15

159

1532

(3005988) Vibrio sp identified in Specimen by Organism specific culture

722

0.93

0.23

1.6

1.4

—

(3024471) HLA-A [Type]

246

1.14

0.23

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

200

0.85

0.23

2.5

2.4

2.46

1.70

mmol/l

0.58

150

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

106

1.22

0.23

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

316

0.88

0.22

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

726

1.07

0.22

1.3

1.5

—

(3044927) Protein electrophoresis panel - Urine

437

1.10

0.22

1.4

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

129

1222

1.05

0.22

1.1

126.43

9074.12

iu/ml

0.64

298

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

162

1.17

0.22

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

162

1.17

0.22

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

162

1.17

0.22

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

162

1.17

0.22

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

720

0.93

0.22

1.6

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

496

1.09

0.21

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

746

7305

1.02

0.21

1.6

971.97

1001.50

mu/l

0.41

643

6291

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.19

0.21

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.5

—

(3022313) Gas panel - Capillary blood

320

3292

0.97

0.21

6.6

6.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

0.17

—

(3004616) Nuclear Ab [Presence] in Serum

827

1.06

0.20

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

421

1.09

0.20

1.7

2.0

1.31

1.71

u/field

0.44

229

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.20

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

417

0.91

0.20

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

211

1.14

0.20

2.5

1.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

716

0.93

0.20

1.6

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.20

0.19

1.0

1.1

1.42

1.64

umol/24h

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

393

1.09

0.19

1.2

1.4

370.74

362.17

u/l

0.04

378

(44806420) Estimation of glomerular filtration rate

818

0.94

0.19

2.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

432

1.09

0.19

1.4

1.3

850.00

998.72

titre

—

(3029396) Erythrocyte agglutination [Presence] in Blood

384

1.09

0.19

3.4

3.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

143

0.84

0.19

1.4

—

(3045788) Cell count panel - Pleural fluid

452

1.08

0.18

1.2

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.23

0.18

1.3

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.23

0.18

1.1

1.2

26.23

42.07

mg/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

138

1.16

0.17

1.0

1.1

—

(3024932) HLA-DR beta [Type]

243

1.11

0.16

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.12

0.16

1.7

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

400

0.92

0.15

1.5

75.43

76.55

umol/l

0.13

400

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

769

0.95

0.15

1.6

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

389

1.08

0.15

1.2

1.1

—

(3033099) Centromere Ab [Titer] in Serum

150

0.86

0.15

1.1

—

(3016750) Collection duration of Urine

274

1.09

0.14

2.6

2.2

513.76

498.84

min

0.46

207

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

148

1427

1.04

0.14

1.4

21.16

21.94

u/l

0.13

131

1196

(3003434) Protein [Mass/volume] in Pleural fluid

585

1.06

0.14

1.2

1.5

34.97

32.81

g/l

0.76

533

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

246

1.10

0.14

1.9

2.7

138.60

126.89

ng/l

0.16

184

(3024522) Salmonella sp identified in Specimen by Organism specific culture

755

0.95

0.13

1.6

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.82

0.13

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

0.82

0.13

2.3

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

397

0.93

0.13

6.4

7.2

9.94

103.23

ug/l

1.05

265

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

103

1.16

0.13

1.4

1.3

5.43

5.56

mmol/l

0.32

103

(3008536) Aspergillus sp Ab [Presence] in Serum

122

1.15

0.13

2.6

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.17

0.13

2.0

2.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

393

1.07

0.12

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

188

1927

0.97

0.12

1.4

3.82

3.97

ug/l

0.09

176

1786

(3020876) Protein [Mass/time] in 24 hour Urine

618

1.05

0.12

2.4

2.5

1.45

1.40

g/24h

0.06

373

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

326

1.07

0.12

1.1

33.14

10.48

u/ml

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

268

1.08

0.11

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

175

1793

0.97

0.11

1.6

1.5

0.38

0.44

nmol/l

0.54

137

1417

(3003129) Base excess in Capillary blood by calculation

618

0.95

0.11

2.5

2.4

1.63

0.48

mmol/l

1.64

579

(3017354) Segmented neutrophils/Leukocytes in Blood

577

0.95

0.11

4.0

3.5

55.64

55.65

0.00

500

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

145

1408

1.03

0.11

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

197

0.91

0.10

2.6

1.8

—

(3006462) Nitrate [Presence] in Urine

278

0.93

0.09

1.8

2.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.11

0.09

1.3

1.2

—

0.69

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

754

0.97

0.08

1.6

1.4

—

(4035726) Immunohistochemistry procedure

481

4748

1.01

0.08

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

449

0.96

0.08

1.6

1.4

197.52

190.52

pmol/l

0.10

449

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

538

1.04

0.08

1.2

56.20

55.33

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

349

3440

1.01

0.08

2.7

3.1

33.13

47.39

u/ml

1.47

338

3332

(3022621) pH of Urine by Test strip

532

5259

1.01

0.07

2.5

6.08

6.14

0.77

343

3392

(3008757) Leukocyte morphology finding [Identifier] in Blood

627

1.04

0.07

2.4

4.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.83

0.07

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

580

0.96

0.07

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

166

1.08

0.07

2.2

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.04

0.07

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

176

1.08

0.07

1.3

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.83

0.07

1.0

—

(40768793) Breast Pathology biopsy report

152

1489

1.02

0.07

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.03

0.07

1.3

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

132

0.91

0.07

1.0

1.1

2.19

6.58

u/ml

2.69

132

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

906

1.03

0.06

1.2

1.3

32.52

33.52

u/l

0.04

785

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

335

0.95

0.06

1.0

1.1

85.84

92.69

0.75

267

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

104

0.86

0.06

23.9

14.3

0.32

0.41

umol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

131

0.91

0.06

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

207

1.06

0.05

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

207

1.06

0.05

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

207

1.06

0.05

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

302

0.96

0.04

1.8

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

109

0.92

0.04

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

110

1083

1.01

0.03

2.2

1.7

2080.00

2246.86

titre

—

(3014271) Vancomycin [Susceptibility]

200

1.05

0.03

2.9

2.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

310

0.97

0.03

1.2

1.1

—

0.13

—

(3035880) pH of Pleural fluid

219

0.96

0.03

1.2

1.4

7.39

7.40

0.10

154

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

290

1.03

0.03

1.2

64.17

68.34

ug/l

0.24

290

(3038071) Oxygen [Partial pressure] in Mixed venous blood

148

0.94

0.02

3.7

6.3

5.19

5.23

kpa

0.05

148

(3006270) Folate [Moles/volume] in Blood

459

1.02

0.02

1.1

404.17

389.50

nmol/l

0.19

414

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

122

1.06

0.02

1.1

1.18

1.20

mom

0.03

122

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

222

1.03

0.02

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

222

1.03

0.02

1.5

1.3

—

(4211845) Urine protein measurement

307

0.98

0.01

1.9

2.7

—

(3004775) Volume in Urine collected for unspecified duration

347

0.98

0.01

2.5

2.3

665.83

621.52

0.17

241

(40765096) Chromosome analysis panel by Banding

183

1.04

0.01

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

542

1.01

0.01

1.2

1.4

1861.62

3814.76

e6/l

0.59

374

(40768795) Lymph node Pathology biopsy report

546

0.99

0.01

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

293

1.02

0.01

1.2

1.1

94.83

295.00

ng/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

363

1.02

0.00

1.8

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

425

0.99

0.00

1.2

1.1

—

(3017704) Immunofixation for Urine

256

1.01

0.00

1.8

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

127

1.02

0.00

1.8

1.6

0.34

0.36

ug/l

0.07

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

135

1.04

0.00

1.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

117

1.02

0.00

4.1

—

(3000034) Microalbumin [Mass/volume] in Urine

435

1.01

0.00

2.6

3.0

18.18

53.07

mg/l

1.39

326

(3013336) Amino acids [Identifier] in Serum or Plasma

1.05

0.00

1.3

2.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

386

1.01

0.00

1.8

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.88

0.00

1.0

1.1

112.00

91.29

titre

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.0

—

0.06

—

(4015189) Microbial culture of sputum

0.92

-0.00

3.4

2.5

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.92

-0.00

1.0

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

4.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.97

-0.00

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.00

-0.00

1.3

1.7

217.14

177.19

mmol/l

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1663.33

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

51.38

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

0.30

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3049233) Organic acids panel - Urine

0.98

-0.00

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_D07AA – D07AA Corticosteroids, weak (group I)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

D07AA Corticosteroids, weak (group I)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for D07AA Corticosteroids, weak (group I) (RX_D07AA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints